id	sid	tid	token	lemma	pos
aji-162	1	1	_	_	PUNCT
aji-162	2	1	_	_	PUNCT
aji-162	3	1	_	_	PUNCT
aji-162	4	1	_	_	PUNCT
aji-162	5	1	_	_	PUNCT
aji-162	6	1	_	_	PUNCT
aji-162	7	1	_	_	PUNCT
aji-162	8	1	_	_	PUNCT
aji-162	9	1	_	_	PUNCT
aji-162	10	1	_	_	PUNCT
aji-162	11	1	_	_	PUNCT
aji-162	12	1	_	_	PUNCT
aji-162	13	1	_	_	PUNCT
aji-162	14	1	_	_	PUNCT
aji-162	15	1	_	_	PUNCT
aji-162	16	1	_	_	PUNCT
aji-162	17	1	_	_	PUNCT
aji-162	18	1	_	_	PUNCT
aji-162	19	1	_	_	PUNCT
aji-162	20	1	_	_	PUNCT
aji-162	21	1	_	_	PUNCT
aji-162	22	1	_	_	PUNCT
aji-162	23	1	_	_	PUNCT
aji-162	24	1	_	_	PUNCT
aji-162	25	1	_	_	PUNCT
aji-162	26	1	_	_	PUNCT
aji-162	27	1	_	_	PUNCT
aji-162	28	1	_	_	PUNCT
aji-162	29	1	_	_	PUNCT
aji-162	30	1	_	_	PUNCT
aji-162	31	1	_	_	PUNCT
aji-162	32	1	_	_	PUNCT
aji-162	33	1	_	_	PUNCT
aji-162	34	1	_	_	PUNCT
aji-162	35	1	_	_	PUNCT
aji-162	36	1	_	_	PUNCT
aji-162	37	1	_	_	PUNCT
aji-162	38	1	_	_	PUNCT
aji-162	39	1	_	_	PUNCT
aji-162	40	1	_	_	PUNCT
aji-162	41	1	_	_	PUNCT
aji-162	42	1	_	_	PUNCT
aji-162	43	1	_	_	PUNCT
aji-162	44	1	_	_	PUNCT
aji-162	45	1	_	_	PUNCT
aji-162	46	1	_	_	PUNCT
aji-162	47	1	_	_	PUNCT
aji-162	48	1	_	_	PUNCT
aji-162	49	1	_	_	PUNCT
aji-162	50	1	_	_	PUNCT
aji-162	51	1	_	_	PUNCT
aji-162	52	1	_	_	PUNCT
aji-162	53	1	_	_	PUNCT
aji-162	54	1	_	_	PUNCT
aji-162	55	1	_	_	PUNCT
aji-162	56	1	_	_	PUNCT
aji-162	57	1	_	_	PUNCT
aji-162	58	1	_	_	PUNCT
aji-162	59	1	_	_	PUNCT
aji-162	60	1	_	_	PUNCT
aji-162	61	1	_	_	PUNCT
aji-162	62	1	_	_	PUNCT
aji-162	63	1	_	_	PUNCT
aji-162	64	1	_	_	PUNCT
aji-162	65	1	_	_	PUNCT
aji-162	66	1	_	_	PUNCT
aji-162	67	1	_	_	PUNCT
aji-162	68	1	_	_	PUNCT
aji-162	69	1	_	_	PUNCT
aji-162	70	1	_	_	PUNCT
aji-162	71	1	_	_	PUNCT
aji-162	72	1	_	_	PUNCT
aji-162	73	1	_	_	PUNCT
aji-162	74	1	_	_	PUNCT
aji-162	75	1	_	_	PUNCT
aji-162	76	1	_	_	PUNCT
aji-162	77	1	_	_	PUNCT
aji-162	78	1	_	_	PUNCT
aji-162	79	1	_	_	PUNCT
aji-162	80	1	_	_	PUNCT
aji-162	81	1	_	_	PUNCT
aji-162	82	1	_	_	PUNCT
aji-162	83	1	_	_	PUNCT
aji-162	84	1	_	_	PUNCT
aji-162	85	1	_	_	PUNCT
aji-162	86	1	_	_	PUNCT
aji-162	87	1	_	_	PUNCT
aji-162	88	1	_	_	PUNCT
aji-162	89	1	_	_	PUNCT
aji-162	90	1	_	_	PUNCT
aji-162	91	1	_	_	PUNCT
aji-162	92	1	_	_	PUNCT
aji-162	93	1	_	_	PUNCT
aji-162	94	1	_	_	PUNCT
aji-162	95	1	_	_	PUNCT
aji-162	96	1	_	_	PUNCT
aji-162	97	1	_	_	PUNCT
aji-162	98	1	_	_	PUNCT
aji-162	99	1	_	_	PUNCT
aji-162	100	1	_	_	PUNCT
aji-162	101	1	_	_	PUNCT
aji-162	102	1	*	*	PUNCT
aji-162	102	2	corresponding	correspond	VERB
aji-162	102	3	author	author	NOUN
aji-162	102	4	:	:	PUNCT
aji-162	102	5	e	e	NOUN
aji-162	102	6	-	-	NOUN
aji-162	102	7	mail	mail	NOUN
aji-162	102	8	:	:	PUNCT
aji-162	102	9	shayanthebest911@gmail.com	shayanthebest911@gmail.com	NUM
aji-162	102	10	;	;	PUNCT
aji-162	102	11	cite	cite	VERB
aji-162	102	12	as	as	ADP
aji-162	102	13	:	:	PUNCT
aji-162	102	14	ashfaq	ashfaq	NOUN
aji-162	102	15	,	,	PUNCT
aji-162	102	16	muhammad	muhammad	PROPN
aji-162	102	17	shayan	shayan	PROPN
aji-162	102	18	,	,	PUNCT
aji-162	102	19	and	and	CCONJ
aji-162	102	20	muhammad	muhammad	PROPN
aji-162	102	21	hasan	hasan	PROPN
aji-162	102	22	.	.	PROPN
aji-162	102	23	2025	2025	NUM
aji-162	102	24	.	.	PUNCT
aji-162	103	1	“	"	PUNCT
aji-162	103	2	anti	anti	ADJ
aji-162	103	3	-	-	ADJ
aji-162	103	4	n	n	DET
aji-162	103	5	antibody	antibody	NOUN
aji-162	103	6	reacting	react	VERB
aji-162	103	7	at	at	ADP
aji-162	103	8	37	37	NUM
aji-162	103	9	°	°	NOUN
aji-162	103	10	c	c	NOUN
aji-162	103	11	:	:	PUNCT
aji-162	103	12	an	an	DET
aji-162	103	13	unusual	unusual	ADJ
aji-162	103	14	reaction	reaction	NOUN
aji-162	103	15	in	in	ADP
aji-162	103	16	antibody	antibody	NOUN
aji-162	103	17	screening	screen	VERB
aji-162	103	18	in	in	ADP
aji-162	103	19	a	a	DET
aji-162	103	20	20	20	NUM
aji-162	103	21	-	-	PUNCT
aji-162	103	22	year	year	NOUN
aji-162	103	23	-	-	PUNCT
aji-162	103	24	old	old	ADJ
aji-162	103	25	male	male	ADJ
aji-162	103	26	liver	liver	NOUN
aji-162	103	27	donor	donor	NOUN
aji-162	103	28	”	"	PUNCT
aji-162	103	29	.	.	PUNCT
aji-162	104	1	asian	asian	ADJ
aji-162	104	2	journal	journal	NOUN
aji-162	104	3	of	of	ADP
aji-162	104	4	immunology	immunology	NOUN
aji-162	104	5	8	8	NUM
aji-162	104	6	(	(	PUNCT
aji-162	104	7	1):82	1):82	NUM
aji-162	104	8	-	-	SYM
aji-162	104	9	85	85	NUM
aji-162	104	10	.	.	PUNCT
aji-162	105	1	https://doi.org/10.9734/aji/2025/v8i1162	https://doi.org/10.9734/aji/2025/v8i1162	PROPN
aji-162	105	2	.	.	PUNCT
aji-162	106	1	asian	asian	PROPN
aji-162	106	2	journal	journal	PROPN
aji-162	106	3	of	of	ADP
aji-162	106	4	immunology	immunology	NOUN
aji-162	106	5	volume	volume	NOUN
aji-162	106	6	8	8	NUM
aji-162	106	7	,	,	PUNCT
aji-162	106	8	issue	issue	NOUN
aji-162	106	9	1	1	NUM
aji-162	106	10	,	,	PUNCT
aji-162	106	11	page	page	NOUN
aji-162	106	12	82	82	NUM
aji-162	106	13	-	-	SYM
aji-162	106	14	85	85	NUM
aji-162	106	15	,	,	PUNCT
aji-162	106	16	2025	2025	NUM
aji-162	106	17	;	;	PUNCT
aji-162	106	18	article	article	NOUN
aji-162	106	19	no.aji.135018	no.aji.135018	PROPN
aji-162	106	20	anti	anti	ADJ
aji-162	106	21	-	-	ADJ
aji-162	106	22	n	n	DET
aji-162	106	23	antibody	antibody	NOUN
aji-162	106	24	reacting	react	VERB
aji-162	106	25	at	at	ADP
aji-162	106	26	37	37	NUM
aji-162	106	27	°	°	NOUN
aji-162	106	28	c	c	NOUN
aji-162	106	29	:	:	PUNCT
aji-162	106	30	an	an	DET
aji-162	106	31	unusual	unusual	ADJ
aji-162	106	32	reaction	reaction	NOUN
aji-162	106	33	in	in	ADP
aji-162	106	34	antibody	antibody	NOUN
aji-162	106	35	screening	screen	VERB
aji-162	106	36	in	in	ADP
aji-162	106	37	a	a	DET
aji-162	106	38	20	20	NUM
aji-162	106	39	-	-	PUNCT
aji-162	106	40	year	year	NOUN
aji-162	106	41	-	-	PUNCT
aji-162	106	42	old	old	ADJ
aji-162	106	43	male	male	ADJ
aji-162	106	44	liver	liver	NOUN
aji-162	106	45	donor	donor	NOUN
aji-162	106	46	muhammad	muhammad	PROPN
aji-162	106	47	shayan	shayan	PROPN
aji-162	106	48	ashfaq	ashfaq	PROPN
aji-162	107	1	a	a	PROPN
aji-162	107	2	*	*	PUNCT
aji-162	107	3	and	and	CCONJ
aji-162	107	4	muhammad	muhammad	PROPN
aji-162	107	5	hasan	hasan	PROPN
aji-162	107	6	a	a	DET
aji-162	107	7	a	a	DET
aji-162	107	8	department	department	NOUN
aji-162	107	9	of	of	ADP
aji-162	107	10	pathology	pathology	NOUN
aji-162	107	11	and	and	CCONJ
aji-162	107	12	laboratory	laboratory	NOUN
aji-162	107	13	medicine	medicine	NOUN
aji-162	107	14	,	,	PUNCT
aji-162	107	15	section	section	NOUN
aji-162	107	16	of	of	ADP
aji-162	107	17	hematology	hematology	NOUN
aji-162	107	18	&	&	CCONJ
aji-162	107	19	transfusion	transfusion	NOUN
aji-162	107	20	medicine	medicine	NOUN
aji-162	107	21	,	,	PUNCT
aji-162	107	22	aga	aga	PROPN
aji-162	107	23	khan	khan	PROPN
aji-162	107	24	university	university	PROPN
aji-162	107	25	hospital	hospital	PROPN
aji-162	107	26	,	,	PUNCT
aji-162	107	27	karachi	karachi	PROPN
aji-162	107	28	,	,	PUNCT
aji-162	107	29	pakistan	pakistan	PROPN
aji-162	107	30	.	.	PUNCT
aji-162	108	1	authors	author	NOUN
aji-162	108	2	’	'	PUNCT
aji-162	108	3	contributions	contribution	NOUN
aji-162	108	4	this	this	DET
aji-162	108	5	work	work	NOUN
aji-162	108	6	was	be	AUX
aji-162	108	7	carried	carry	VERB
aji-162	108	8	out	out	ADP
aji-162	108	9	in	in	ADP
aji-162	108	10	collaboration	collaboration	NOUN
aji-162	108	11	between	between	ADP
aji-162	108	12	both	both	DET
aji-162	108	13	authors	author	NOUN
aji-162	108	14	.	.	PUNCT
aji-162	109	1	authors	author	NOUN
aji-162	109	2	msa	msa	PROPN
aji-162	109	3	and	and	CCONJ
aji-162	109	4	mh	mh	PROPN
aji-162	109	5	contributed	contribute	VERB
aji-162	109	6	to	to	ADP
aji-162	109	7	the	the	DET
aji-162	109	8	design	design	NOUN
aji-162	109	9	,	,	PUNCT
aji-162	109	10	drafting	drafting	NOUN
aji-162	109	11	and	and	CCONJ
aji-162	109	12	critical	critical	ADJ
aji-162	109	13	revision	revision	NOUN
aji-162	109	14	of	of	ADP
aji-162	109	15	the	the	DET
aji-162	109	16	manuscript	manuscript	NOUN
aji-162	109	17	.	.	PUNCT
aji-162	110	1	both	both	DET
aji-162	110	2	authors	author	NOUN
aji-162	110	3	read	read	VERB
aji-162	110	4	and	and	CCONJ
aji-162	110	5	approved	approve	VERB
aji-162	110	6	the	the	DET
aji-162	110	7	final	final	ADJ
aji-162	110	8	manuscript	manuscript	NOUN
aji-162	110	9	.	.	PUNCT
aji-162	111	1	article	article	NOUN
aji-162	111	2	information	information	PROPN
aji-162	111	3	doi	doi	PROPN
aji-162	111	4	:	:	PUNCT
aji-162	111	5	https://doi.org/10.9734/aji/2025/v8i1162	https://doi.org/10.9734/aji/2025/v8i1162	PROPN
aji-162	111	6	open	open	ADJ
aji-162	111	7	peer	peer	NOUN
aji-162	111	8	review	review	NOUN
aji-162	111	9	history	history	NOUN
aji-162	111	10	:	:	PUNCT
aji-162	111	11	this	this	DET
aji-162	111	12	journal	journal	NOUN
aji-162	111	13	follows	follow	VERB
aji-162	111	14	the	the	DET
aji-162	111	15	advanced	advance	VERB
aji-162	111	16	open	open	ADJ
aji-162	111	17	peer	peer	NOUN
aji-162	111	18	review	review	NOUN
aji-162	111	19	policy	policy	NOUN
aji-162	111	20	.	.	PUNCT
aji-162	112	1	identity	identity	NOUN
aji-162	112	2	of	of	ADP
aji-162	112	3	the	the	DET
aji-162	112	4	reviewers	reviewer	NOUN
aji-162	112	5	,	,	PUNCT
aji-162	112	6	editor(s	editor(s	NOUN
aji-162	112	7	)	)	PUNCT
aji-162	112	8	and	and	CCONJ
aji-162	112	9	additional	additional	ADJ
aji-162	112	10	reviewers	reviewer	NOUN
aji-162	112	11	,	,	PUNCT
aji-162	112	12	peer	peer	NOUN
aji-162	112	13	review	review	NOUN
aji-162	112	14	comments	comment	NOUN
aji-162	112	15	,	,	PUNCT
aji-162	112	16	different	different	ADJ
aji-162	112	17	versions	version	NOUN
aji-162	112	18	of	of	ADP
aji-162	112	19	the	the	DET
aji-162	112	20	manuscript	manuscript	NOUN
aji-162	112	21	,	,	PUNCT
aji-162	112	22	comments	comment	NOUN
aji-162	112	23	of	of	ADP
aji-162	112	24	the	the	DET
aji-162	112	25	editors	editor	NOUN
aji-162	112	26	,	,	PUNCT
aji-162	112	27	etc	etc	X
aji-162	112	28	are	be	AUX
aji-162	112	29	available	available	ADJ
aji-162	112	30	here	here	ADV
aji-162	112	31	:	:	PUNCT
aji-162	112	32	https://pr.sdiarticle5.com/review-history/135018	https://pr.sdiarticle5.com/review-history/135018	NOUN
aji-162	112	33	received	receive	VERB
aji-162	112	34	:	:	PUNCT
aji-162	112	35	23/02/2025	23/02/2025	NUM
aji-162	112	36	published	publish	VERB
aji-162	112	37	:	:	PUNCT
aji-162	112	38	29/04/2025	29/04/2025	NUM
aji-162	112	39	abstract	abstract	ADJ
aji-162	112	40	anti	anti	ADJ
aji-162	112	41	-	-	ADJ
aji-162	112	42	n	n	ADJ
aji-162	112	43	antibodies	antibody	NOUN
aji-162	112	44	usually	usually	ADV
aji-162	112	45	possess	possess	VERB
aji-162	112	46	cold	cold	ADJ
aji-162	112	47	-	-	PUNCT
aji-162	112	48	reactive	reactive	ADJ
aji-162	112	49	properties	property	NOUN
aji-162	112	50	which	which	PRON
aji-162	112	51	make	make	VERB
aji-162	112	52	them	they	PRON
aji-162	112	53	clinically	clinically	ADV
aji-162	112	54	insignificant	insignificant	ADJ
aji-162	112	55	and	and	CCONJ
aji-162	112	56	are	be	AUX
aji-162	112	57	mostly	mostly	ADV
aji-162	112	58	classified	classify	VERB
aji-162	112	59	as	as	ADP
aji-162	112	60	naturally	naturally	ADV
aji-162	112	61	occurring	occur	VERB
aji-162	112	62	igm	igm	PROPN
aji-162	112	63	antibodies	antibodie	VERB
aji-162	112	64	.	.	PUNCT
aji-162	113	1	these	these	DET
aji-162	113	2	antibodies	antibodie	VERB
aji-162	113	3	sometimes	sometimes	ADV
aji-162	113	4	trigger	trigger	VERB
aji-162	113	5	reactions	reaction	NOUN
aji-162	113	6	at	at	ADP
aji-162	113	7	body	body	NOUN
aji-162	113	8	temperature	temperature	NOUN
aji-162	113	9	(	(	PUNCT
aji-162	113	10	37	37	NUM
aji-162	113	11	°	°	NUM
aji-162	113	12	c	c	NOUN
aji-162	113	13	)	)	PUNCT
aji-162	113	14	or	or	CCONJ
aji-162	113	15	in	in	ADP
aji-162	113	16	the	the	DET
aji-162	113	17	anti	anti	ADJ
aji-162	113	18	-	-	ADJ
aji-162	113	19	human	human	ADJ
aji-162	113	20	globulin	globulin	NOUN
aji-162	113	21	phase	phase	NOUN
aji-162	113	22	resulting	result	VERB
aji-162	113	23	in	in	ADP
aji-162	113	24	serious	serious	ADJ
aji-162	113	25	medical	medical	ADJ
aji-162	113	26	outcomes	outcome	NOUN
aji-162	113	27	such	such	ADJ
aji-162	113	28	as	as	ADP
aji-162	113	29	delayed	delay	VERB
aji-162	113	30	hemolytic	hemolytic	ADJ
aji-162	113	31	transfusion	transfusion	NOUN
aji-162	113	32	reactions	reaction	NOUN
aji-162	113	33	or	or	CCONJ
aji-162	113	34	hemolytic	hemolytic	ADJ
aji-162	113	35	disease	disease	NOUN
aji-162	113	36	of	of	ADP
aji-162	113	37	the	the	DET
aji-162	113	38	newborn	newborn	ADJ
aji-162	113	39	.	.	PUNCT
aji-162	114	1	this	this	DET
aji-162	114	2	case	case	NOUN
aji-162	114	3	shows	show	VERB
aji-162	114	4	an	an	DET
aji-162	114	5	extraordinary	extraordinary	ADJ
aji-162	114	6	naturally	naturally	ADV
aji-162	114	7	occurring	occur	VERB
aji-162	114	8	anti	anti	ADJ
aji-162	114	9	-	-	ADJ
aji-162	114	10	n	n	PRON
aji-162	114	11	antibody	antibody	NOUN
aji-162	114	12	which	which	PRON
aji-162	114	13	was	be	AUX
aji-162	114	14	detected	detect	VERB
aji-162	114	15	in	in	ADP
aji-162	114	16	a	a	DET
aji-162	114	17	20	20	NUM
aji-162	114	18	-	-	PUNCT
aji-162	114	19	year	year	NOUN
aji-162	114	20	-	-	PUNCT
aji-162	114	21	old	old	ADJ
aji-162	114	22	male	male	ADJ
aji-162	114	23	liver	liver	NOUN
aji-162	114	24	donor	donor	NOUN
aji-162	114	25	during	during	ADP
aji-162	114	26	standard	standard	ADJ
aji-162	114	27	antibody	antibody	NOUN
aji-162	114	28	testing	testing	NOUN
aji-162	114	29	because	because	SCONJ
aji-162	114	30	of	of	ADP
aji-162	114	31	its	its	PRON
aji-162	114	32	unexpected	unexpected	ADJ
aji-162	114	33	reactivity	reactivity	NOUN
aji-162	114	34	at	at	ADP
aji-162	114	35	37	37	NUM
aji-162	114	36	°	°	NOUN
aji-162	114	37	c	c	NOUN
aji-162	114	38	.	.	PUNCT
aji-162	115	1	the	the	DET
aji-162	115	2	absence	absence	NOUN
aji-162	115	3	of	of	ADP
aji-162	115	4	any	any	DET
aji-162	115	5	previous	previous	ADJ
aji-162	115	6	blood	blood	NOUN
aji-162	115	7	transfusions	transfusion	NOUN
aji-162	115	8	or	or	CCONJ
aji-162	115	9	medication	medication	NOUN
aji-162	115	10	use	use	NOUN
aji-162	115	11	in	in	ADP
aji-162	115	12	the	the	DET
aji-162	115	13	patient	patient	NOUN
aji-162	115	14	made	make	VERB
aji-162	115	15	this	this	DET
aji-162	115	16	case	case	NOUN
aji-162	115	17	stand	stand	VERB
aji-162	115	18	out	out	ADP
aji-162	115	19	as	as	ADV
aji-162	115	20	particularly	particularly	ADV
aji-162	115	21	intriguing	intriguing	ADJ
aji-162	115	22	.	.	PUNCT
aji-162	116	1	the	the	DET
aji-162	116	2	antibody	antibody	NOUN
aji-162	116	3	identification	identification	NOUN
aji-162	116	4	was	be	AUX
aji-162	116	5	successful	successful	ADJ
aji-162	116	6	case	case	NOUN
aji-162	116	7	report	report	NOUN
aji-162	116	8	https://doi.org/10.9734/aji/2025/v8i1162	https://doi.org/10.9734/aji/2025/v8i1162	PROPN
aji-162	116	9	https://pr.sdiarticle5.com/review-history/135018	https://pr.sdiarticle5.com/review-history/135018	NOUN
aji-162	116	10	ashfaq	ashfaq	NOUN
aji-162	116	11	and	and	CCONJ
aji-162	116	12	hasan	hasan	PROPN
aji-162	116	13	;	;	PUNCT
aji-162	116	14	asian	asian	PROPN
aji-162	116	15	j.	j.	PROPN
aji-162	116	16	immunol	immunol	PROPN
aji-162	116	17	.	.	PROPN
aji-162	116	18	,	,	PUNCT
aji-162	116	19	vol	vol	NOUN
aji-162	116	20	.	.	PROPN
aji-162	116	21	8	8	NUM
aji-162	116	22	,	,	PUNCT
aji-162	116	23	no	no	INTJ
aji-162	116	24	.	.	NOUN
aji-162	116	25	1	1	NUM
aji-162	116	26	,	,	PUNCT
aji-162	116	27	pp	pp	ADJ
aji-162	116	28	.	.	PUNCT
aji-162	117	1	82	82	NUM
aji-162	117	2	-	-	SYM
aji-162	117	3	85	85	NUM
aji-162	117	4	,	,	PUNCT
aji-162	117	5	2025	2025	NUM
aji-162	117	6	;	;	PUNCT
aji-162	117	7	article	article	NOUN
aji-162	117	8	no.aji.135018	no.aji.135018	NOUN
aji-162	117	9	83	83	NUM
aji-162	117	10	following	follow	VERB
aji-162	117	11	the	the	DET
aji-162	117	12	'	'	PUNCT
aji-162	117	13	pre	pre	ADJ
aji-162	117	14	-	-	ADJ
aji-162	117	15	warm	warm	ADJ
aji-162	117	16	'	'	PUNCT
aji-162	117	17	technique	technique	NOUN
aji-162	117	18	implementation	implementation	NOUN
aji-162	117	19	while	while	SCONJ
aji-162	117	20	antigen	antigen	ADJ
aji-162	117	21	phenotyping	phenotype	VERB
aji-162	117	22	validated	validate	VERB
aji-162	117	23	it	it	PRON
aji-162	117	24	as	as	ADP
aji-162	117	25	an	an	DET
aji-162	117	26	iggtype	iggtype	NOUN
aji-162	117	27	anti	anti	ADJ
aji-162	117	28	-	-	ADJ
aji-162	117	29	n	n	PRON
aji-162	117	30	antibody	antibody	NOUN
aji-162	117	31	.	.	PUNCT
aji-162	118	1	this	this	DET
aji-162	118	2	medical	medical	ADJ
aji-162	118	3	case	case	NOUN
aji-162	118	4	demonstrates	demonstrate	VERB
aji-162	118	5	the	the	DET
aji-162	118	6	critical	critical	ADJ
aji-162	118	7	importance	importance	NOUN
aji-162	118	8	of	of	ADP
aji-162	118	9	recognizing	recognize	VERB
aji-162	118	10	unusual	unusual	ADJ
aji-162	118	11	antibody	antibody	NOUN
aji-162	118	12	responses	response	NOUN
aji-162	118	13	during	during	ADP
aji-162	118	14	blood	blood	NOUN
aji-162	118	15	transfusions	transfusion	NOUN
aji-162	118	16	and	and	CCONJ
aji-162	118	17	organ	organ	NOUN
aji-162	118	18	transplants	transplant	NOUN
aji-162	118	19	because	because	SCONJ
aji-162	118	20	uncommon	uncommon	ADJ
aji-162	118	21	reactions	reaction	NOUN
aji-162	118	22	may	may	AUX
aji-162	118	23	lead	lead	VERB
aji-162	118	24	to	to	ADP
aji-162	118	25	serious	serious	ADJ
aji-162	118	26	consequences	consequence	NOUN
aji-162	118	27	.	.	PUNCT
aji-162	119	1	keywords	keyword	NOUN
aji-162	119	2	:	:	PUNCT
aji-162	119	3	anti	anti	ADJ
aji-162	119	4	-	-	ADJ
aji-162	119	5	n	n	PRON
aji-162	119	6	antibody	antibody	NOUN
aji-162	119	7	;	;	PUNCT
aji-162	119	8	mns	mns	PROPN
aji-162	119	9	blood	blood	NOUN
aji-162	119	10	group	group	NOUN
aji-162	119	11	system	system	NOUN
aji-162	119	12	;	;	PUNCT
aji-162	119	13	transfusion	transfusion	NOUN
aji-162	119	14	medicine	medicine	NOUN
aji-162	119	15	;	;	PUNCT
aji-162	119	16	serological	serological	ADJ
aji-162	119	17	testing	testing	NOUN
aji-162	119	18	;	;	PUNCT
aji-162	119	19	delayed	delay	VERB
aji-162	119	20	hemolytic	hemolytic	ADJ
aji-162	119	21	transfusion	transfusion	NOUN
aji-162	119	22	reactions	reaction	NOUN
aji-162	119	23	.	.	PUNCT
aji-162	120	1	1	1	X
aji-162	120	2	.	.	X
aji-162	120	3	introduction	introduction	NOUN
aji-162	120	4	the	the	DET
aji-162	120	5	mns	mns	PROPN
aji-162	120	6	blood	blood	NOUN
aji-162	120	7	group	group	NOUN
aji-162	120	8	system	system	NOUN
aji-162	120	9	,	,	PUNCT
aji-162	120	10	discovered	discover	VERB
aji-162	120	11	by	by	ADP
aji-162	120	12	landsteiner	landsteiner	NOUN
aji-162	120	13	and	and	CCONJ
aji-162	120	14	levine	levine	PROPN
aji-162	120	15	in	in	ADP
aji-162	120	16	1927	1927	NUM
aji-162	120	17	,	,	PUNCT
aji-162	120	18	was	be	AUX
aji-162	120	19	the	the	DET
aji-162	120	20	second	second	ADJ
aji-162	120	21	to	to	PART
aji-162	120	22	be	be	AUX
aji-162	120	23	identified	identify	VERB
aji-162	120	24	after	after	ADP
aji-162	120	25	the	the	DET
aji-162	120	26	abo	abo	NOUN
aji-162	120	27	system	system	NOUN
aji-162	120	28	.	.	PUNCT
aji-162	121	1	among	among	ADP
aji-162	121	2	the	the	DET
aji-162	121	3	antibodies	antibody	NOUN
aji-162	121	4	in	in	ADP
aji-162	121	5	the	the	DET
aji-162	121	6	mns	mns	PROPN
aji-162	121	7	system	system	NOUN
aji-162	121	8	,	,	PUNCT
aji-162	121	9	anti	anti	ADJ
aji-162	121	10	-	-	ADJ
aji-162	121	11	m	m	NOUN
aji-162	121	12	is	be	AUX
aji-162	121	13	a	a	DET
aji-162	121	14	common	common	ADJ
aji-162	121	15	"	"	PUNCT
aji-162	121	16	naturally	naturally	ADV
aji-162	121	17	occurring	occur	VERB
aji-162	121	18	"	"	PUNCT
aji-162	121	19	antibody	antibody	NOUN
aji-162	121	20	(	(	PUNCT
aji-162	121	21	perrault	perrault	NOUN
aji-162	121	22	,	,	PUNCT
aji-162	121	23	1973	1973	NUM
aji-162	121	24	)	)	PUNCT
aji-162	121	25	.	.	PUNCT
aji-162	122	1	the	the	DET
aji-162	122	2	s	s	NOUN
aji-162	122	3	antigen	antigen	NOUN
aji-162	122	4	was	be	AUX
aji-162	122	5	identified	identify	VERB
aji-162	122	6	in	in	ADP
aji-162	122	7	1947	1947	NUM
aji-162	122	8	by	by	ADP
aji-162	122	9	walsh	walsh	PROPN
aji-162	122	10	and	and	CCONJ
aji-162	122	11	montgomery	montgomery	PROPN
aji-162	122	12	after	after	ADP
aji-162	122	13	the	the	DET
aji-162	122	14	development	development	NOUN
aji-162	122	15	of	of	ADP
aji-162	122	16	the	the	DET
aji-162	122	17	antiglobulin	antiglobulin	PROPN
aji-162	122	18	test	test	NOUN
aji-162	122	19	(	(	PUNCT
aji-162	122	20	harmening	harmening	ADJ
aji-162	122	21	,	,	PUNCT
aji-162	122	22	2018	2018	NUM
aji-162	122	23	)	)	PUNCT
aji-162	122	24	.	.	PUNCT
aji-162	123	1	most	most	ADJ
aji-162	123	2	anti	anti	ADJ
aji-162	123	3	-	-	ADJ
aji-162	123	4	m	m	ADJ
aji-162	123	5	antibodies	antibody	NOUN
aji-162	123	6	are	be	AUX
aji-162	123	7	cold	cold	ADJ
aji-162	123	8	-	-	PUNCT
aji-162	123	9	reactive	reactive	ADJ
aji-162	123	10	and	and	CCONJ
aji-162	123	11	do	do	AUX
aji-162	123	12	not	not	PART
aji-162	123	13	activate	activate	VERB
aji-162	123	14	complement	complement	NOUN
aji-162	123	15	or	or	CCONJ
aji-162	123	16	react	react	VERB
aji-162	123	17	with	with	ADP
aji-162	123	18	enzymetreated	enzymetreated	ADJ
aji-162	123	19	rbcs	rbc	NOUN
aji-162	123	20	(	(	PUNCT
aji-162	123	21	thakral	thakral	PROPN
aji-162	123	22	et	et	PROPN
aji-162	123	23	al	al	PROPN
aji-162	123	24	.	.	PROPN
aji-162	123	25	,	,	PUNCT
aji-162	123	26	2010	2010	NUM
aji-162	123	27	)	)	PUNCT
aji-162	123	28	.	.	PUNCT
aji-162	124	1	they	they	PRON
aji-162	124	2	are	be	AUX
aji-162	124	3	rarely	rarely	ADV
aji-162	124	4	associated	associate	VERB
aji-162	124	5	with	with	ADP
aji-162	124	6	hemolytic	hemolytic	ADJ
aji-162	124	7	transfusion	transfusion	NOUN
aji-162	124	8	reactions	reaction	NOUN
aji-162	124	9	(	(	PUNCT
aji-162	124	10	sancho	sancho	PROPN
aji-162	124	11	et	et	PROPN
aji-162	124	12	al	al	PROPN
aji-162	124	13	.	.	PROPN
aji-162	124	14	,	,	PUNCT
aji-162	124	15	1998	1998	NUM
aji-162	124	16	)	)	PUNCT
aji-162	124	17	.	.	PUNCT
aji-162	125	1	anti	anti	ADJ
aji-162	125	2	-	-	ADJ
aji-162	125	3	n	n	ADJ
aji-162	125	4	antibodies	antibody	NOUN
aji-162	125	5	are	be	AUX
aji-162	125	6	less	less	ADV
aji-162	125	7	common	common	ADJ
aji-162	125	8	than	than	ADP
aji-162	125	9	anti	anti	ADJ
aji-162	125	10	-	-	ADJ
aji-162	125	11	m	m	PRON
aji-162	125	12	and	and	CCONJ
aji-162	125	13	are	be	AUX
aji-162	125	14	also	also	ADV
aji-162	125	15	typically	typically	ADV
aji-162	125	16	naturally	naturally	ADV
aji-162	125	17	occurring	occur	VERB
aji-162	125	18	,	,	PUNCT
aji-162	125	19	coldreactive	coldreactive	ADJ
aji-162	125	20	igm	igm	NOUN
aji-162	125	21	or	or	CCONJ
aji-162	125	22	igg	igg	PROPN
aji-162	125	23	agglutinins	agglutinin	NOUN
aji-162	125	24	that	that	PRON
aji-162	125	25	do	do	AUX
aji-162	125	26	not	not	PART
aji-162	125	27	activate	activate	VERB
aji-162	125	28	complement	complement	NOUN
aji-162	125	29	or	or	CCONJ
aji-162	125	30	react	react	VERB
aji-162	125	31	with	with	ADP
aji-162	125	32	enzymetreated	enzymetreated	ADJ
aji-162	125	33	rbcs	rbc	NOUN
aji-162	125	34	(	(	PUNCT
aji-162	125	35	perrault	perrault	NOUN
aji-162	125	36	,	,	PUNCT
aji-162	125	37	1973	1973	NUM
aji-162	125	38	;	;	PUNCT
aji-162	125	39	taj	taj	PROPN
aji-162	125	40	et	et	PROPN
aji-162	125	41	al	al	PROPN
aji-162	125	42	.	.	PROPN
aji-162	125	43	,	,	PUNCT
aji-162	125	44	2025	2025	NUM
aji-162	125	45	)	)	PUNCT
aji-162	125	46	.	.	PUNCT
aji-162	126	1	they	they	PRON
aji-162	126	2	are	be	AUX
aji-162	126	3	clinically	clinically	ADV
aji-162	126	4	insignificant	insignificant	ADJ
aji-162	126	5	unless	unless	SCONJ
aji-162	126	6	reactive	reactive	NOUN
aji-162	126	7	at	at	ADP
aji-162	126	8	37	37	NUM
aji-162	126	9	°	°	ADP
aji-162	126	10	c	c	NOUN
aji-162	126	11	and	and	CCONJ
aji-162	126	12	have	have	AUX
aji-162	126	13	been	be	AUX
aji-162	126	14	linked	link	VERB
aji-162	126	15	to	to	ADP
aji-162	126	16	rare	rare	ADJ
aji-162	126	17	cases	case	NOUN
aji-162	126	18	of	of	ADP
aji-162	126	19	mild	mild	ADJ
aji-162	126	20	hemolytic	hemolytic	ADJ
aji-162	126	21	disease	disease	NOUN
aji-162	126	22	of	of	ADP
aji-162	126	23	the	the	DET
aji-162	126	24	fetus	fetus	NOUN
aji-162	126	25	and	and	CCONJ
aji-162	126	26	newborn	newborn	ADJ
aji-162	126	27	(	(	PUNCT
aji-162	126	28	hdfn	hdfn	NOUN
aji-162	126	29	)	)	PUNCT
aji-162	126	30	(	(	PUNCT
aji-162	126	31	ballas	ballas	PROPN
aji-162	126	32	et	et	PROPN
aji-162	126	33	al	al	PROPN
aji-162	126	34	.	.	PROPN
aji-162	126	35	,	,	PUNCT
aji-162	126	36	1985	1985	NUM
aji-162	126	37	;	;	PUNCT
aji-162	126	38	wiebe	wiebe	PROPN
aji-162	126	39	et	et	PROPN
aji-162	126	40	al	al	PROPN
aji-162	126	41	.	.	PROPN
aji-162	126	42	,	,	PUNCT
aji-162	126	43	2024	2024	NUM
aji-162	126	44	)	)	PUNCT
aji-162	126	45	.	.	PUNCT
aji-162	127	1	potent	potent	ADJ
aji-162	127	2	anti	anti	ADJ
aji-162	127	3	-	-	ADJ
aji-162	127	4	n	n	ADJ
aji-162	127	5	antibodies	antibody	NOUN
aji-162	127	6	are	be	AUX
aji-162	127	7	more	more	ADV
aji-162	127	8	frequently	frequently	ADV
aji-162	127	9	found	find	VERB
aji-162	127	10	in	in	ADP
aji-162	127	11	individuals	individual	NOUN
aji-162	127	12	of	of	ADP
aji-162	127	13	african	african	ADJ
aji-162	127	14	descent	descent	NOUN
aji-162	127	15	with	with	ADP
aji-162	127	16	a	a	DET
aji-162	127	17	specific	specific	ADJ
aji-162	127	18	rbc	rbc	PROPN
aji-162	127	19	phenotype	phenotype	NOUN
aji-162	127	20	(	(	PUNCT
aji-162	127	21	m+	m+	NOUN
aji-162	127	22	nss-	nss-	PART
aji-162	127	23	)	)	PUNCT
aji-162	127	24	due	due	ADP
aji-162	127	25	to	to	ADP
aji-162	127	26	the	the	DET
aji-162	127	27	absence	absence	NOUN
aji-162	127	28	of	of	ADP
aji-162	127	29	the	the	DET
aji-162	127	30	n	n	ADV
aji-162	127	31	antigen	antigen	NOUN
aji-162	127	32	(	(	PUNCT
aji-162	127	33	harmening	harmening	ADJ
aji-162	127	34	,	,	PUNCT
aji-162	127	35	2018	2018	NUM
aji-162	127	36	;	;	PUNCT
aji-162	127	37	katagiri	katagiri	NOUN
aji-162	127	38	et	et	PROPN
aji-162	127	39	al	al	PROPN
aji-162	127	40	.	.	PROPN
aji-162	127	41	,	,	PUNCT
aji-162	127	42	2024	2024	NUM
aji-162	127	43	)	)	PUNCT
aji-162	127	44	.	.	PUNCT
aji-162	128	1	immune	immune	ADJ
aji-162	128	2	anti	anti	ADJ
aji-162	128	3	-	-	ADJ
aji-162	128	4	n	n	ADJ
aji-162	128	5	antibodies	antibody	NOUN
aji-162	128	6	are	be	AUX
aji-162	128	7	extremely	extremely	ADV
aji-162	128	8	rare	rare	ADJ
aji-162	128	9	(	(	PUNCT
aji-162	128	10	klein	klein	PROPN
aji-162	128	11	&	&	CCONJ
aji-162	128	12	anstee	anstee	PROPN
aji-162	128	13	,	,	PUNCT
aji-162	128	14	2013	2013	NUM
aji-162	128	15	)	)	PUNCT
aji-162	128	16	.	.	PUNCT
aji-162	129	1	we	we	PRON
aji-162	129	2	report	report	VERB
aji-162	129	3	a	a	DET
aji-162	129	4	case	case	NOUN
aji-162	129	5	of	of	ADP
aji-162	129	6	naturally	naturally	ADV
aji-162	129	7	occurring	occur	VERB
aji-162	129	8	anti	anti	NOUN
aji-162	129	9	-	-	ADJ
aji-162	129	10	n	n	PRON
aji-162	129	11	that	that	PRON
aji-162	129	12	reacts	react	VERB
aji-162	129	13	at	at	ADP
aji-162	129	14	37	37	NUM
aji-162	129	15	°	°	NOUN
aji-162	129	16	c	c	NOUN
aji-162	129	17	,	,	PUNCT
aji-162	129	18	identified	identify	VERB
aji-162	129	19	during	during	ADP
aji-162	129	20	routine	routine	ADJ
aji-162	129	21	antibody	antibody	NOUN
aji-162	129	22	identification	identification	NOUN
aji-162	129	23	testing	testing	NOUN
aji-162	129	24	(	(	PUNCT
aji-162	129	25	kumawat	kumawat	VERB
aji-162	129	26	et	et	PROPN
aji-162	129	27	al	al	PROPN
aji-162	129	28	.	.	PROPN
aji-162	129	29	,	,	PUNCT
aji-162	129	30	2015	2015	NUM
aji-162	129	31	)	)	PUNCT
aji-162	129	32	.	.	PUNCT
aji-162	130	1	2	2	X
aji-162	130	2	.	.	X
aji-162	130	3	case	case	NOUN
aji-162	130	4	report	report	VERB
aji-162	130	5	a	a	DET
aji-162	130	6	20	20	NUM
aji-162	130	7	-	-	PUNCT
aji-162	130	8	year	year	NOUN
aji-162	130	9	-	-	PUNCT
aji-162	130	10	old	old	ADJ
aji-162	130	11	guy	guy	NOUN
aji-162	130	12	from	from	ADP
aji-162	130	13	karachi	karachi	PROPN
aji-162	130	14	,	,	PUNCT
aji-162	130	15	who	who	PRON
aji-162	130	16	’s	’	VERB
aji-162	130	17	healthy	healthy	ADJ
aji-162	130	18	and	and	CCONJ
aji-162	130	19	does	do	AUX
aji-162	130	20	n't	not	PART
aji-162	130	21	have	have	VERB
aji-162	130	22	any	any	DET
aji-162	130	23	other	other	ADJ
aji-162	130	24	medical	medical	ADJ
aji-162	130	25	issues	issue	NOUN
aji-162	130	26	,	,	PUNCT
aji-162	130	27	decided	decide	VERB
aji-162	130	28	to	to	PART
aji-162	130	29	donate	donate	VERB
aji-162	130	30	a	a	DET
aji-162	130	31	liver	liver	NOUN
aji-162	130	32	to	to	ADP
aji-162	130	33	his	his	PRON
aji-162	130	34	dad	dad	NOUN
aji-162	130	35	.	.	PUNCT
aji-162	131	1	his	his	PRON
aji-162	131	2	father	father	NOUN
aji-162	131	3	had	have	AUX
aji-162	131	4	been	be	AUX
aji-162	131	5	struggling	struggle	VERB
aji-162	131	6	with	with	ADP
aji-162	131	7	chronic	chronic	ADJ
aji-162	131	8	liver	liver	NOUN
aji-162	131	9	disease	disease	NOUN
aji-162	131	10	because	because	SCONJ
aji-162	131	11	of	of	ADP
aji-162	131	12	a	a	DET
aji-162	131	13	hepatitis	hepatitis	NOUN
aji-162	131	14	b	b	NOUN
aji-162	131	15	infection	infection	NOUN
aji-162	131	16	,	,	PUNCT
aji-162	131	17	so	so	ADV
aji-162	131	18	they	they	PRON
aji-162	131	19	set	set	VERB
aji-162	131	20	up	up	ADP
aji-162	131	21	a	a	DET
aji-162	131	22	liver	liver	NOUN
aji-162	131	23	transplant	transplant	NOUN
aji-162	131	24	at	at	ADP
aji-162	131	25	dow	dow	PROPN
aji-162	131	26	university	university	PROPN
aji-162	131	27	of	of	ADP
aji-162	131	28	health	health	PROPN
aji-162	131	29	sciences	sciences	PROPN
aji-162	131	30	.	.	PUNCT
aji-162	132	1	this	this	DET
aji-162	132	2	donor	donor	NOUN
aji-162	132	3	had	have	AUX
aji-162	132	4	never	never	ADV
aji-162	132	5	had	have	VERB
aji-162	132	6	a	a	DET
aji-162	132	7	blood	blood	NOUN
aji-162	132	8	transfusion	transfusion	NOUN
aji-162	132	9	or	or	CCONJ
aji-162	132	10	taken	take	VERB
aji-162	132	11	any	any	DET
aji-162	132	12	medication	medication	NOUN
aji-162	132	13	.	.	PUNCT
aji-162	133	1	for	for	ADP
aji-162	133	2	the	the	DET
aji-162	133	3	usual	usual	ADJ
aji-162	133	4	pre	pre	ADJ
aji-162	133	5	-	-	ADJ
aji-162	133	6	transplant	transplant	ADJ
aji-162	133	7	checks	check	NOUN
aji-162	133	8	,	,	PUNCT
aji-162	133	9	they	they	PRON
aji-162	133	10	sent	send	VERB
aji-162	133	11	a	a	DET
aji-162	133	12	test	test	NOUN
aji-162	133	13	request	request	NOUN
aji-162	133	14	to	to	PART
aji-162	133	15	aga	aga	PROPN
aji-162	133	16	khan	khan	PROPN
aji-162	133	17	university	university	PROPN
aji-162	133	18	hospital	hospital	NOUN
aji-162	133	19	to	to	PART
aji-162	133	20	identify	identify	VERB
aji-162	133	21	any	any	DET
aji-162	133	22	antibodies	antibody	NOUN
aji-162	133	23	.	.	PUNCT
aji-162	134	1	the	the	DET
aji-162	134	2	first	first	ADJ
aji-162	134	3	blood	blood	NOUN
aji-162	134	4	tests	test	NOUN
aji-162	134	5	came	come	VERB
aji-162	134	6	back	back	ADV
aji-162	134	7	showing	show	VERB
aji-162	134	8	a	a	DET
aji-162	134	9	positive	positive	ADJ
aji-162	134	10	auto	auto	NOUN
aji-162	134	11	-	-	PUNCT
aji-162	134	12	control	control	NOUN
aji-162	134	13	,	,	PUNCT
aji-162	134	14	which	which	PRON
aji-162	134	15	means	mean	VERB
aji-162	134	16	his	his	PRON
aji-162	134	17	red	red	ADJ
aji-162	134	18	blood	blood	NOUN
aji-162	134	19	cells	cell	NOUN
aji-162	134	20	reacted	react	VERB
aji-162	134	21	with	with	ADP
aji-162	134	22	his	his	PRON
aji-162	134	23	own	own	ADJ
aji-162	134	24	serum	serum	NOUN
aji-162	134	25	at	at	ADP
aji-162	134	26	room	room	NOUN
aji-162	134	27	temperature	temperature	NOUN
aji-162	134	28	.	.	PUNCT
aji-162	135	1	but	but	CCONJ
aji-162	135	2	when	when	SCONJ
aji-162	135	3	they	they	PRON
aji-162	135	4	did	do	VERB
aji-162	135	5	a	a	DET
aji-162	135	6	direct	direct	ADJ
aji-162	135	7	antiglobulin	antiglobulin	NOUN
aji-162	135	8	test	test	NOUN
aji-162	135	9	(	(	PUNCT
aji-162	135	10	dat	dat	PROPN
aji-162	135	11	)	)	PUNCT
aji-162	135	12	with	with	ADP
aji-162	135	13	anti	anti	ADJ
aji-162	135	14	-	-	ADJ
aji-162	135	15	igg	igg	ADJ
aji-162	135	16	+	+	CCONJ
aji-162	135	17	c3d	c3d	NOUN
aji-162	135	18	,	,	PUNCT
aji-162	135	19	it	it	PRON
aji-162	135	20	came	come	VERB
aji-162	135	21	back	back	ADV
aji-162	135	22	negative	negative	ADJ
aji-162	135	23	,	,	PUNCT
aji-162	135	24	ruling	rule	VERB
aji-162	135	25	out	out	ADP
aji-162	135	26	any	any	DET
aji-162	135	27	autoantibodies	autoantibody	NOUN
aji-162	135	28	.	.	PUNCT
aji-162	136	1	they	they	PRON
aji-162	136	2	then	then	ADV
aji-162	136	3	checked	check	VERB
aji-162	136	4	three	three	NUM
aji-162	136	5	different	different	ADJ
aji-162	136	6	antibody	antibody	NOUN
aji-162	136	7	screening	screen	VERB
aji-162	136	8	panels	panel	NOUN
aji-162	136	9	(	(	PUNCT
aji-162	136	10	id	id	NOUN
aji-162	136	11	-	-	PUNCT
aji-162	136	12	diacell	diacell	ADJ
aji-162	136	13	iii	iii	PROPN
aji-162	136	14	-	-	PUNCT
aji-162	136	15	iii	iii	NOUN
aji-162	136	16	,	,	PUNCT
aji-162	136	17	biorad	biorad	NOUN
aji-162	136	18	)	)	PUNCT
aji-162	136	19	and	and	CCONJ
aji-162	136	20	found	find	VERB
aji-162	136	21	positive	positive	ADJ
aji-162	136	22	reactions	reaction	NOUN
aji-162	136	23	in	in	ADP
aji-162	136	24	all	all	PRON
aji-162	136	25	of	of	ADP
aji-162	136	26	them	they	PRON
aji-162	136	27	(	(	PUNCT
aji-162	136	28	2	2	NUM
aji-162	136	29	+	+	ADJ
aji-162	136	30	,	,	PUNCT
aji-162	136	31	3	3	NUM
aji-162	136	32	+	+	ADJ
aji-162	136	33	,	,	PUNCT
aji-162	136	34	and	and	CCONJ
aji-162	136	35	3	3	NUM
aji-162	136	36	+	+	NUM
aji-162	136	37	)	)	PUNCT
aji-162	136	38	.	.	PUNCT
aji-162	137	1	they	they	PRON
aji-162	137	2	also	also	ADV
aji-162	137	3	noticed	notice	VERB
aji-162	137	4	that	that	SCONJ
aji-162	137	5	the	the	DET
aji-162	137	6	auto	auto	NOUN
aji-162	137	7	-	-	PUNCT
aji-162	137	8	control	control	NOUN
aji-162	137	9	was	be	AUX
aji-162	137	10	positive	positive	ADJ
aji-162	137	11	right	right	ADV
aji-162	137	12	from	from	ADP
aji-162	137	13	the	the	DET
aji-162	137	14	spin	spin	NOUN
aji-162	137	15	phase	phase	NOUN
aji-162	137	16	.	.	PUNCT
aji-162	138	1	so	so	ADV
aji-162	138	2	,	,	PUNCT
aji-162	138	3	they	they	PRON
aji-162	138	4	decided	decide	VERB
aji-162	138	5	to	to	PART
aji-162	138	6	run	run	VERB
aji-162	138	7	the	the	DET
aji-162	138	8	antibody	antibody	NOUN
aji-162	138	9	screening	screen	VERB
aji-162	138	10	again	again	ADV
aji-162	138	11	using	use	VERB
aji-162	138	12	a	a	DET
aji-162	138	13	method	method	NOUN
aji-162	138	14	where	where	SCONJ
aji-162	138	15	they	they	PRON
aji-162	138	16	warmed	warm	VERB
aji-162	138	17	everything	everything	PRON
aji-162	138	18	up	up	ADP
aji-162	138	19	,	,	PUNCT
aji-162	138	20	and	and	CCONJ
aji-162	138	21	surprise	surprise	VERB
aji-162	138	22	!	!	PUNCT
aji-162	139	1	they	they	PRON
aji-162	139	2	got	get	VERB
aji-162	139	3	positive	positive	ADJ
aji-162	139	4	results	result	NOUN
aji-162	139	5	across	across	ADP
aji-162	139	6	all	all	DET
aji-162	139	7	three	three	NUM
aji-162	139	8	panels	panel	NOUN
aji-162	139	9	.	.	PUNCT
aji-162	140	1	to	to	PART
aji-162	140	2	dig	dig	VERB
aji-162	140	3	deeper	deeply	ADV
aji-162	140	4	,	,	PUNCT
aji-162	140	5	they	they	PRON
aji-162	140	6	used	use	VERB
aji-162	140	7	the	the	DET
aji-162	140	8	papain	papain	NOUN
aji-162	140	9	treatment	treatment	NOUN
aji-162	140	10	method	method	NOUN
aji-162	140	11	(	(	PUNCT
aji-162	140	12	id	id	NOUN
aji-162	140	13	-	-	PUNCT
aji-162	140	14	diacell	diacell	ADJ
aji-162	140	15	papain	papain	NOUN
aji-162	140	16	kit	kit	NOUN
aji-162	140	17	)	)	PUNCT
aji-162	140	18	,	,	PUNCT
aji-162	140	19	which	which	PRON
aji-162	140	20	surprisingly	surprisingly	ADV
aji-162	140	21	turned	turn	VERB
aji-162	140	22	up	up	ADP
aji-162	140	23	a	a	DET
aji-162	140	24	negative	negative	ADJ
aji-162	140	25	result	result	NOUN
aji-162	140	26	for	for	ADP
aji-162	140	27	the	the	DET
aji-162	140	28	red	red	ADJ
aji-162	140	29	cell	cell	NOUN
aji-162	140	30	antibody	antibody	NOUN
aji-162	140	31	screening	screen	VERB
aji-162	140	32	.	.	PUNCT
aji-162	141	1	but	but	CCONJ
aji-162	141	2	when	when	SCONJ
aji-162	141	3	they	they	PRON
aji-162	141	4	went	go	VERB
aji-162	141	5	ahead	ahead	ADV
aji-162	141	6	with	with	ADP
aji-162	141	7	the	the	DET
aji-162	141	8	antibody	antibody	NOUN
aji-162	141	9	identification	identification	NOUN
aji-162	141	10	using	use	VERB
aji-162	141	11	the	the	DET
aji-162	141	12	warm	warm	ADJ
aji-162	141	13	technique	technique	NOUN
aji-162	141	14	,	,	PUNCT
aji-162	141	15	they	they	PRON
aji-162	141	16	found	find	VERB
aji-162	141	17	out	out	ADP
aji-162	141	18	he	he	PRON
aji-162	141	19	had	have	VERB
aji-162	141	20	an	an	DET
aji-162	141	21	anti	anti	ADJ
aji-162	141	22	-	-	ADJ
aji-162	141	23	n	n	PRON
aji-162	141	24	antibody	antibody	NOUN
aji-162	141	25	using	use	VERB
aji-162	141	26	this	this	DET
aji-162	141	27	11	11	NUM
aji-162	141	28	-	-	PUNCT
aji-162	141	29	cell	cell	NOUN
aji-162	141	30	identification	identification	NOUN
aji-162	141	31	panel	panel	NOUN
aji-162	141	32	(	(	PUNCT
aji-162	141	33	id	id	NOUN
aji-162	141	34	-	-	PUNCT
aji-162	141	35	diacell	diacell	ADJ
aji-162	141	36	,	,	PUNCT
aji-162	141	37	biorad	biorad	NOUN
aji-162	141	38	)	)	PUNCT
aji-162	141	39	.	.	PUNCT
aji-162	142	1	the	the	DET
aji-162	142	2	reaction	reaction	NOUN
aji-162	142	3	was	be	AUX
aji-162	142	4	pretty	pretty	ADV
aji-162	142	5	strong	strong	ADJ
aji-162	142	6	,	,	PUNCT
aji-162	142	7	3	3	NUM
aji-162	142	8	+	+	ADJ
aji-162	142	9	,	,	PUNCT
aji-162	142	10	with	with	ADP
aji-162	142	11	homozygous	homozygous	ADJ
aji-162	142	12	n+	n+	NUM
aji-162	142	13	n+	n+	PUNCT
aji-162	142	14	cells	cell	NOUN
aji-162	142	15	(	(	PUNCT
aji-162	142	16	panels	panel	NOUN
aji-162	142	17	4	4	NUM
aji-162	142	18	,	,	PUNCT
aji-162	142	19	10	10	NUM
aji-162	142	20	,	,	PUNCT
aji-162	142	21	and	and	CCONJ
aji-162	142	22	11	11	NUM
aji-162	142	23	)	)	PUNCT
aji-162	142	24	and	and	CCONJ
aji-162	142	25	negative	negative	ADJ
aji-162	142	26	with	with	ADP
aji-162	142	27	heterozygous	heterozygous	ADJ
aji-162	142	28	m+	m+	NUM
aji-162	142	29	n+	n+	NUM
aji-162	142	30	cells	cell	NOUN
aji-162	142	31	(	(	PUNCT
aji-162	142	32	panels	panel	NOUN
aji-162	142	33	1	1	NUM
aji-162	142	34	,	,	PUNCT
aji-162	142	35	3	3	NUM
aji-162	142	36	,	,	PUNCT
aji-162	142	37	7	7	NUM
aji-162	142	38	,	,	PUNCT
aji-162	142	39	and	and	CCONJ
aji-162	142	40	8)	8)	NUM
aji-162	142	41	,	,	PUNCT
aji-162	142	42	plus	plus	CCONJ
aji-162	142	43	also	also	ADV
aji-162	142	44	negative	negative	ADJ
aji-162	142	45	with	with	ADP
aji-162	142	46	nnegative	nnegative	ADJ
aji-162	142	47	cells	cell	NOUN
aji-162	142	48	(	(	PUNCT
aji-162	142	49	panels	panel	NOUN
aji-162	142	50	2	2	NUM
aji-162	142	51	,	,	PUNCT
aji-162	142	52	5	5	NUM
aji-162	142	53	,	,	PUNCT
aji-162	142	54	6	6	NUM
aji-162	142	55	,	,	PUNCT
aji-162	142	56	and	and	CCONJ
aji-162	142	57	9	9	NUM
aji-162	142	58	)	)	PUNCT
aji-162	142	59	.	.	PUNCT
aji-162	143	1	they	they	PRON
aji-162	143	2	also	also	ADV
aji-162	143	3	checked	check	VERB
aji-162	143	4	other	other	ADJ
aji-162	143	5	antigens	antigen	NOUN
aji-162	143	6	for	for	ADP
aji-162	143	7	n	n	CCONJ
aji-162	143	8	,	,	PUNCT
aji-162	143	9	s	s	PROPN
aji-162	143	10	,	,	PUNCT
aji-162	143	11	s	s	X
aji-162	143	12	,	,	PUNCT
aji-162	143	13	and	and	CCONJ
aji-162	143	14	m	m	PROPN
aji-162	143	15	and	and	CCONJ
aji-162	143	16	found	find	VERB
aji-162	143	17	that	that	SCONJ
aji-162	143	18	he	he	PRON
aji-162	143	19	was	be	AUX
aji-162	143	20	m-	m-	PROPN
aji-162	143	21	,	,	PUNCT
aji-162	143	22	n-	n-	X
aji-162	143	23	,	,	PUNCT
aji-162	143	24	s-	s-	X
aji-162	143	25	,	,	PUNCT
aji-162	143	26	and	and	CCONJ
aji-162	143	27	s-	s-	X
aji-162	143	28	.	.	PUNCT
aji-162	144	1	they	they	PRON
aji-162	144	2	treated	treat	VERB
aji-162	144	3	his	his	PRON
aji-162	144	4	plasma	plasma	NOUN
aji-162	144	5	with	with	ADP
aji-162	144	6	dithiothreitol	dithiothreitol	PROPN
aji-162	144	7	,	,	PUNCT
aji-162	144	8	which	which	PRON
aji-162	144	9	confirmed	confirm	VERB
aji-162	144	10	there	there	PRON
aji-162	144	11	was	be	VERB
aji-162	144	12	an	an	DET
aji-162	144	13	igg	igg	NOUN
aji-162	144	14	-	-	PUNCT
aji-162	144	15	type	type	NOUN
aji-162	144	16	anti	anti	ADJ
aji-162	144	17	-	-	ADJ
aji-162	144	18	n	n	PRON
aji-162	144	19	antibody	antibody	NOUN
aji-162	144	20	present	present	ADJ
aji-162	144	21	.	.	PUNCT
aji-162	145	1	the	the	DET
aji-162	145	2	antibody	antibody	NOUN
aji-162	145	3	titer	titer	NOUN
aji-162	145	4	was	be	AUX
aji-162	145	5	1:2	1:2	NUM
aji-162	145	6	.	.	PUNCT
aji-162	146	1	this	this	DET
aji-162	146	2	report	report	NOUN
aji-162	146	3	emphasizes	emphasize	VERB
aji-162	146	4	a	a	DET
aji-162	146	5	naturally	naturally	ADV
aji-162	146	6	occurring	occur	VERB
aji-162	146	7	anti	anti	ADJ
aji-162	146	8	-	-	ADJ
aji-162	146	9	n	n	PRON
aji-162	146	10	antibody	antibody	NOUN
aji-162	146	11	that	that	PRON
aji-162	146	12	reacts	react	VERB
aji-162	146	13	at	at	ADP
aji-162	146	14	37	37	NUM
aji-162	146	15	°	°	NOUN
aji-162	146	16	c	c	NOUN
aji-162	146	17	,	,	PUNCT
aji-162	146	18	which	which	PRON
aji-162	146	19	could	could	AUX
aji-162	146	20	actually	actually	ADV
aji-162	146	21	be	be	AUX
aji-162	146	22	pretty	pretty	ADV
aji-162	146	23	important	important	ADJ
aji-162	146	24	even	even	ADV
aji-162	146	25	though	though	SCONJ
aji-162	146	26	the	the	DET
aji-162	146	27	donor	donor	NOUN
aji-162	146	28	had	have	AUX
aji-162	146	29	n’t	not	PART
aji-162	146	30	had	have	VERB
aji-162	146	31	any	any	DET
aji-162	146	32	blood	blood	NOUN
aji-162	146	33	transfusions	transfusion	NOUN
aji-162	146	34	before	before	ADV
aji-162	146	35	.	.	PUNCT
aji-162	147	1	it	it	PRON
aji-162	147	2	really	really	ADV
aji-162	147	3	brings	bring	VERB
aji-162	147	4	home	home	ADV
aji-162	147	5	the	the	DET
aji-162	147	6	need	need	NOUN
aji-162	147	7	to	to	PART
aji-162	147	8	check	check	VERB
aji-162	147	9	for	for	ADP
aji-162	147	10	these	these	PRON
aji-162	147	11	naturally	naturally	ADV
aji-162	147	12	happening	happen	VERB
aji-162	147	13	antibodies	antibody	NOUN
aji-162	147	14	during	during	ADP
aji-162	147	15	routine	routine	ADJ
aji-162	147	16	blood	blood	NOUN
aji-162	147	17	tests	test	NOUN
aji-162	147	18	because	because	SCONJ
aji-162	147	19	their	their	PRON
aji-162	147	20	reactions	reaction	NOUN
aji-162	147	21	at	at	ADP
aji-162	147	22	body	body	NOUN
aji-162	147	23	temperature	temperature	NOUN
aji-162	147	24	can	can	AUX
aji-162	147	25	affect	affect	VERB
aji-162	147	26	transfusion	transfusion	NOUN
aji-162	147	27	practices	practice	NOUN
aji-162	147	28	.	.	PUNCT
aji-162	148	1	3	3	X
aji-162	148	2	.	.	X
aji-162	148	3	discussion	discussion	NOUN
aji-162	148	4	anti	anti	ADJ
aji-162	148	5	-	-	ADJ
aji-162	148	6	n	n	ADJ
aji-162	148	7	antibodies	antibody	NOUN
aji-162	148	8	belong	belong	VERB
aji-162	148	9	to	to	ADP
aji-162	148	10	the	the	DET
aji-162	148	11	mns	mns	PROPN
aji-162	148	12	blood	blood	NOUN
aji-162	148	13	group	group	NOUN
aji-162	148	14	system	system	NOUN
aji-162	148	15	and	and	CCONJ
aji-162	148	16	are	be	AUX
aji-162	148	17	usually	usually	ADV
aji-162	148	18	naturally	naturally	ADV
aji-162	148	19	occurring	occur	VERB
aji-162	148	20	and	and	CCONJ
aji-162	148	21	mainly	mainly	ADV
aji-162	148	22	cold	cold	ADJ
aji-162	148	23	-	-	PUNCT
aji-162	148	24	reactive	reactive	ADJ
aji-162	148	25	igm	igm	PROPN
aji-162	148	26	antibodies	antibodie	VERB
aji-162	148	27	.	.	PUNCT
aji-162	149	1	these	these	DET
aji-162	149	2	antibodies	antibody	NOUN
aji-162	149	3	are	be	AUX
aji-162	149	4	often	often	ADV
aji-162	149	5	clinically	clinically	ADV
aji-162	149	6	insignificant	insignificant	ADJ
aji-162	149	7	unless	unless	SCONJ
aji-162	149	8	they	they	PRON
aji-162	149	9	decide	decide	VERB
aji-162	149	10	to	to	PART
aji-162	149	11	react	react	VERB
aji-162	149	12	at	at	ADP
aji-162	149	13	37	37	NUM
aji-162	149	14	°	°	ADP
aji-162	149	15	c	c	NOUN
aji-162	149	16	or	or	CCONJ
aji-162	149	17	during	during	ADP
aji-162	149	18	the	the	DET
aji-162	149	19	antihuman	antihuman	NOUN
aji-162	149	20	globulin	globulin	NOUN
aji-162	149	21	(	(	PUNCT
aji-162	149	22	ahg	ahg	PROPN
aji-162	149	23	)	)	PUNCT
aji-162	149	24	phase	phase	NOUN
aji-162	149	25	of	of	ADP
aji-162	149	26	testing	testing	NOUN
aji-162	149	27	.	.	PUNCT
aji-162	150	1	in	in	ADP
aji-162	150	2	this	this	DET
aji-162	150	3	ashfaq	ashfaq	NOUN
aji-162	150	4	and	and	CCONJ
aji-162	150	5	hasan	hasan	PROPN
aji-162	150	6	;	;	PUNCT
aji-162	150	7	asian	asian	PROPN
aji-162	150	8	j.	j.	PROPN
aji-162	150	9	immunol	immunol	PROPN
aji-162	150	10	.	.	PROPN
aji-162	150	11	,	,	PUNCT
aji-162	150	12	vol	vol	NOUN
aji-162	150	13	.	.	PROPN
aji-162	150	14	8	8	NUM
aji-162	150	15	,	,	PUNCT
aji-162	150	16	no	no	INTJ
aji-162	150	17	.	.	NOUN
aji-162	150	18	1	1	NUM
aji-162	150	19	,	,	PUNCT
aji-162	150	20	pp	pp	ADJ
aji-162	150	21	.	.	PUNCT
aji-162	151	1	82	82	NUM
aji-162	151	2	-	-	SYM
aji-162	151	3	85	85	NUM
aji-162	151	4	,	,	PUNCT
aji-162	151	5	2025	2025	NUM
aji-162	151	6	;	;	PUNCT
aji-162	151	7	article	article	NOUN
aji-162	151	8	no.aji.135018	no.aji.135018	NOUN
aji-162	151	9	84	84	NUM
aji-162	151	10	case	case	NOUN
aji-162	151	11	,	,	PUNCT
aji-162	151	12	we	we	PRON
aji-162	151	13	found	find	VERB
aji-162	151	14	the	the	DET
aji-162	151	15	anti	anti	ADJ
aji-162	151	16	-	-	ADJ
aji-162	151	17	n	n	PRON
aji-162	151	18	antibody	antibody	NOUN
aji-162	151	19	in	in	ADP
aji-162	151	20	a	a	DET
aji-162	151	21	20	20	NUM
aji-162	151	22	-	-	PUNCT
aji-162	151	23	yearold	yearold	NUM
aji-162	151	24	male	male	ADJ
aji-162	151	25	liver	liver	NOUN
aji-162	151	26	donor	donor	NOUN
aji-162	151	27	who	who	PRON
aji-162	151	28	had	have	VERB
aji-162	151	29	a	a	DET
aji-162	151	30	serological	serological	ADJ
aji-162	151	31	profile	profile	NOUN
aji-162	151	32	showing	show	VERB
aji-162	151	33	an	an	DET
aji-162	151	34	uncommon	uncommon	ADJ
aji-162	151	35	blood	blood	NOUN
aji-162	151	36	group	group	NOUN
aji-162	151	37	discrepancy	discrepancy	NOUN
aji-162	151	38	.	.	PUNCT
aji-162	152	1	while	while	SCONJ
aji-162	152	2	anti	anti	ADJ
aji-162	152	3	-	-	ADJ
aji-162	152	4	n	n	ADJ
aji-162	152	5	antibodies	antibody	NOUN
aji-162	152	6	are	be	AUX
aji-162	152	7	generally	generally	ADV
aji-162	152	8	more	more	ADJ
aji-162	152	9	of	of	ADP
aji-162	152	10	a	a	DET
aji-162	152	11	cold	cold	ADJ
aji-162	152	12	-	-	PUNCT
aji-162	152	13	reactive	reactive	ADJ
aji-162	152	14	type	type	NOUN
aji-162	152	15	and	and	CCONJ
aji-162	152	16	do	do	AUX
aji-162	152	17	n’t	not	PART
aji-162	152	18	usually	usually	ADV
aji-162	152	19	bind	bind	VERB
aji-162	152	20	complement	complement	NOUN
aji-162	152	21	,	,	PUNCT
aji-162	152	22	if	if	SCONJ
aji-162	152	23	they	they	PRON
aji-162	152	24	do	do	AUX
aji-162	152	25	react	react	VERB
aji-162	152	26	at	at	ADP
aji-162	152	27	37	37	NUM
aji-162	152	28	°	°	NOUN
aji-162	152	29	c	c	NOUN
aji-162	152	30	,	,	PUNCT
aji-162	152	31	that	that	PRON
aji-162	152	32	’s	’	VERB
aji-162	152	33	when	when	SCONJ
aji-162	152	34	we	we	PRON
aji-162	152	35	start	start	VERB
aji-162	152	36	to	to	PART
aji-162	152	37	worry	worry	VERB
aji-162	152	38	about	about	ADP
aji-162	152	39	their	their	PRON
aji-162	152	40	clinical	clinical	ADJ
aji-162	152	41	significance	significance	NOUN
aji-162	152	42	.	.	PUNCT
aji-162	153	1	normally	normally	ADV
aji-162	153	2	,	,	PUNCT
aji-162	153	3	anti	anti	ADJ
aji-162	153	4	-	-	ADJ
aji-162	153	5	n	n	ADJ
aji-162	153	6	antibodies	antibody	NOUN
aji-162	153	7	do	do	AUX
aji-162	153	8	n’t	not	PART
aji-162	153	9	cause	cause	VERB
aji-162	153	10	major	major	ADJ
aji-162	153	11	issues	issue	NOUN
aji-162	153	12	,	,	PUNCT
aji-162	153	13	as	as	SCONJ
aji-162	153	14	they	they	PRON
aji-162	153	15	are	be	AUX
aji-162	153	16	linked	link	VERB
aji-162	153	17	to	to	ADP
aji-162	153	18	non	non	ADJ
aji-162	153	19	-	-	ADJ
aji-162	153	20	pathological	pathological	ADJ
aji-162	153	21	clinical	clinical	ADJ
aji-162	153	22	outcomes	outcome	NOUN
aji-162	153	23	.	.	PUNCT
aji-162	154	1	they	they	PRON
aji-162	154	2	typically	typically	ADV
aji-162	154	3	do	do	AUX
aji-162	154	4	n't	not	PART
aji-162	154	5	lead	lead	VERB
aji-162	154	6	to	to	ADP
aji-162	154	7	hemolytic	hemolytic	ADJ
aji-162	154	8	transfusion	transfusion	NOUN
aji-162	154	9	reactions	reaction	NOUN
aji-162	154	10	(	(	PUNCT
aji-162	154	11	htrs	htrs	PROPN
aji-162	154	12	)	)	PUNCT
aji-162	154	13	or	or	CCONJ
aji-162	154	14	hemolytic	hemolytic	ADJ
aji-162	154	15	disease	disease	NOUN
aji-162	154	16	of	of	ADP
aji-162	154	17	the	the	DET
aji-162	154	18	fetus	fetus	NOUN
aji-162	154	19	and	and	CCONJ
aji-162	154	20	newborn	newborn	ADJ
aji-162	154	21	(	(	PUNCT
aji-162	154	22	hdfn	hdfn	NOUN
aji-162	154	23	)	)	PUNCT
aji-162	154	24	unless	unless	SCONJ
aji-162	154	25	we	we	PRON
aji-162	154	26	see	see	VERB
aji-162	154	27	them	they	PRON
aji-162	154	28	react	react	VERB
aji-162	154	29	at	at	ADP
aji-162	154	30	body	body	NOUN
aji-162	154	31	temperature	temperature	NOUN
aji-162	154	32	(	(	PUNCT
aji-162	154	33	37	37	NUM
aji-162	154	34	°	°	NUM
aji-162	154	35	c	c	NOUN
aji-162	154	36	)	)	PUNCT
aji-162	154	37	,	,	PUNCT
aji-162	154	38	like	like	ADP
aji-162	154	39	in	in	ADP
aji-162	154	40	this	this	DET
aji-162	154	41	instance	instance	NOUN
aji-162	154	42	(	(	PUNCT
aji-162	154	43	perrault	perrault	PROPN
aji-162	154	44	,	,	PUNCT
aji-162	154	45	1973	1973	NUM
aji-162	154	46	)	)	PUNCT
aji-162	154	47	.	.	PUNCT
aji-162	155	1	a	a	DET
aji-162	155	2	transfusion	transfusion	NOUN
aji-162	155	3	reaction	reaction	NOUN
aji-162	155	4	is	be	AUX
aji-162	155	5	more	more	ADV
aji-162	155	6	likely	likely	ADJ
aji-162	155	7	if	if	SCONJ
aji-162	155	8	these	these	DET
aji-162	155	9	antibodies	antibody	NOUN
aji-162	155	10	show	show	VERB
aji-162	155	11	strong	strong	ADJ
aji-162	155	12	reactivity	reactivity	NOUN
aji-162	155	13	at	at	ADP
aji-162	155	14	37	37	NUM
aji-162	155	15	°	°	NOUN
aji-162	155	16	c	c	NOUN
aji-162	155	17	,	,	PUNCT
aji-162	155	18	but	but	CCONJ
aji-162	155	19	that	that	PRON
aji-162	155	20	's	be	AUX
aji-162	155	21	pretty	pretty	ADV
aji-162	155	22	rare	rare	ADJ
aji-162	155	23	.	.	PUNCT
aji-162	156	1	when	when	SCONJ
aji-162	156	2	it	it	PRON
aji-162	156	3	happens	happen	VERB
aji-162	156	4	,	,	PUNCT
aji-162	156	5	it	it	PRON
aji-162	156	6	can	can	AUX
aji-162	156	7	cause	cause	VERB
aji-162	156	8	delayed	delay	VERB
aji-162	156	9	hemolytic	hemolytic	ADJ
aji-162	156	10	reactions	reaction	NOUN
aji-162	156	11	,	,	PUNCT
aji-162	156	12	resulting	result	VERB
aji-162	156	13	in	in	ADP
aji-162	156	14	some	some	DET
aji-162	156	15	transfusion	transfusion	NOUN
aji-162	156	16	-	-	PUNCT
aji-162	156	17	associated	associate	VERB
aji-162	156	18	complications	complication	NOUN
aji-162	156	19	.	.	PUNCT
aji-162	157	1	besides	besides	SCONJ
aji-162	157	2	,	,	PUNCT
aji-162	157	3	while	while	SCONJ
aji-162	157	4	hdfn	hdfn	NOUN
aji-162	157	5	can	can	AUX
aji-162	157	6	be	be	AUX
aji-162	157	7	a	a	DET
aji-162	157	8	concern	concern	NOUN
aji-162	157	9	in	in	ADP
aji-162	157	10	cases	case	NOUN
aji-162	157	11	of	of	ADP
aji-162	157	12	maternal	maternal	ADJ
aji-162	157	13	-	-	PUNCT
aji-162	157	14	fetal	fetal	ADJ
aji-162	157	15	blood	blood	NOUN
aji-162	157	16	group	group	NOUN
aji-162	157	17	incompatibility	incompatibility	NOUN
aji-162	157	18	,	,	PUNCT
aji-162	157	19	instances	instance	NOUN
aji-162	157	20	of	of	ADP
aji-162	157	21	hdfn	hdfn	NOUN
aji-162	157	22	linked	link	VERB
aji-162	157	23	to	to	ADP
aji-162	157	24	anti	anti	ADJ
aji-162	157	25	-	-	ADJ
aji-162	157	26	n	n	ADJ
aji-162	157	27	are	be	AUX
aji-162	157	28	super	super	ADV
aji-162	157	29	rare	rare	ADJ
aji-162	157	30	(	(	PUNCT
aji-162	157	31	harmening	harmening	ADJ
aji-162	157	32	,	,	PUNCT
aji-162	157	33	2018	2018	NUM
aji-162	157	34	)	)	PUNCT
aji-162	157	35	.	.	PUNCT
aji-162	158	1	interestingly	interestingly	ADV
aji-162	158	2	,	,	PUNCT
aji-162	158	3	the	the	DET
aji-162	158	4	igm	igm	PROPN
aji-162	158	5	class	class	NOUN
aji-162	158	6	of	of	ADP
aji-162	158	7	anti	anti	ADJ
aji-162	158	8	-	-	ADJ
aji-162	158	9	n	n	ADJ
aji-162	158	10	antibodies	antibody	NOUN
aji-162	158	11	usually	usually	ADV
aji-162	158	12	reacts	react	VERB
aji-162	158	13	in	in	ADP
aji-162	158	14	colder	cold	ADJ
aji-162	158	15	conditions	condition	NOUN
aji-162	158	16	and	and	CCONJ
aji-162	158	17	does	do	AUX
aji-162	158	18	n’t	not	PART
aji-162	158	19	typically	typically	ADV
aji-162	158	20	bind	bind	VERB
aji-162	158	21	to	to	PART
aji-162	158	22	complement	complement	VERB
aji-162	158	23	or	or	CCONJ
aji-162	158	24	react	react	VERB
aji-162	158	25	with	with	ADP
aji-162	158	26	enzyme	enzyme	NOUN
aji-162	158	27	-	-	PUNCT
aji-162	158	28	treated	treat	VERB
aji-162	158	29	red	red	ADJ
aji-162	158	30	blood	blood	NOUN
aji-162	158	31	cells	cell	NOUN
aji-162	158	32	(	(	PUNCT
aji-162	158	33	rbcs	rbc	NOUN
aji-162	158	34	)	)	PUNCT
aji-162	158	35	.	.	PUNCT
aji-162	159	1	this	this	PRON
aji-162	159	2	is	be	AUX
aji-162	159	3	kind	kind	ADV
aji-162	159	4	of	of	ADV
aji-162	159	5	similar	similar	ADJ
aji-162	159	6	to	to	ADP
aji-162	159	7	anti	anti	ADJ
aji-162	159	8	-	-	ADJ
aji-162	159	9	m	m	ADJ
aji-162	159	10	antibodies	antibody	NOUN
aji-162	159	11	,	,	PUNCT
aji-162	159	12	which	which	PRON
aji-162	159	13	show	show	VERB
aji-162	159	14	the	the	DET
aji-162	159	15	same	same	ADJ
aji-162	159	16	cold	cold	ADJ
aji-162	159	17	-	-	PUNCT
aji-162	159	18	reactive	reactive	ADJ
aji-162	159	19	behavior	behavior	NOUN
aji-162	159	20	and	and	CCONJ
aji-162	159	21	limited	limited	ADJ
aji-162	159	22	clinical	clinical	ADJ
aji-162	159	23	relevance	relevance	NOUN
aji-162	159	24	,	,	PUNCT
aji-162	159	25	unless	unless	SCONJ
aji-162	159	26	they	they	PRON
aji-162	159	27	react	react	VERB
aji-162	159	28	at	at	ADP
aji-162	159	29	body	body	NOUN
aji-162	159	30	temperature	temperature	NOUN
aji-162	159	31	(	(	PUNCT
aji-162	159	32	thakral	thakral	PROPN
aji-162	159	33	et	et	PROPN
aji-162	159	34	al	al	PROPN
aji-162	159	35	.	.	PROPN
aji-162	159	36	,	,	PUNCT
aji-162	159	37	2010	2010	NUM
aji-162	159	38	)	)	PUNCT
aji-162	159	39	.	.	PUNCT
aji-162	160	1	however	however	ADV
aji-162	160	2	,	,	PUNCT
aji-162	160	3	in	in	ADP
aji-162	160	4	our	our	PRON
aji-162	160	5	case	case	NOUN
aji-162	160	6	,	,	PUNCT
aji-162	160	7	the	the	DET
aji-162	160	8	antibody	antibody	NOUN
aji-162	160	9	was	be	AUX
aji-162	160	10	behaving	behave	VERB
aji-162	160	11	unusually	unusually	ADV
aji-162	160	12	by	by	ADP
aji-162	160	13	reacting	react	VERB
aji-162	160	14	at	at	ADP
aji-162	160	15	37	37	NUM
aji-162	160	16	°	°	NOUN
aji-162	160	17	c	c	NOUN
aji-162	160	18	,	,	PUNCT
aji-162	160	19	reminding	remind	VERB
aji-162	160	20	us	we	PRON
aji-162	160	21	to	to	PART
aji-162	160	22	stay	stay	VERB
aji-162	160	23	on	on	ADP
aji-162	160	24	our	our	PRON
aji-162	160	25	toes	toe	NOUN
aji-162	160	26	about	about	ADP
aji-162	160	27	atypical	atypical	ADJ
aji-162	160	28	antibody	antibody	NOUN
aji-162	160	29	behaviors	behavior	NOUN
aji-162	160	30	in	in	ADP
aji-162	160	31	blood	blood	NOUN
aji-162	160	32	donors	donor	NOUN
aji-162	160	33	,	,	PUNCT
aji-162	160	34	especially	especially	ADV
aji-162	160	35	when	when	SCONJ
aji-162	160	36	we	we	PRON
aji-162	160	37	’re	’re	AUX
aji-162	160	38	talking	talk	VERB
aji-162	160	39	about	about	ADP
aji-162	160	40	organ	organ	NOUN
aji-162	160	41	transplant	transplant	NOUN
aji-162	160	42	recipients	recipient	NOUN
aji-162	160	43	who	who	PRON
aji-162	160	44	might	might	AUX
aji-162	160	45	need	need	VERB
aji-162	160	46	careful	careful	ADJ
aji-162	160	47	crossmatching	crossmatching	NOUN
aji-162	160	48	and	and	CCONJ
aji-162	160	49	serologic	serologic	NOUN
aji-162	160	50	evaluations	evaluation	NOUN
aji-162	160	51	.	.	PUNCT
aji-162	161	1	the	the	DET
aji-162	161	2	phenotyping	phenotype	VERB
aji-162	161	3	results	result	NOUN
aji-162	161	4	were	be	AUX
aji-162	161	5	pretty	pretty	ADV
aji-162	161	6	noteworthy	noteworthy	ADJ
aji-162	161	7	since	since	SCONJ
aji-162	161	8	the	the	DET
aji-162	161	9	donor	donor	NOUN
aji-162	161	10	's	's	PART
aji-162	161	11	red	red	ADJ
aji-162	161	12	cell	cell	NOUN
aji-162	161	13	antigen	antigen	NOUN
aji-162	161	14	profile	profile	NOUN
aji-162	161	15	showed	show	VERB
aji-162	161	16	the	the	DET
aji-162	161	17	absence	absence	NOUN
aji-162	161	18	of	of	ADP
aji-162	161	19	the	the	DET
aji-162	161	20	m	m	PROPN
aji-162	161	21	,	,	PUNCT
aji-162	161	22	n	n	CCONJ
aji-162	161	23	,	,	PUNCT
aji-162	161	24	s	s	X
aji-162	161	25	,	,	PUNCT
aji-162	161	26	and	and	CCONJ
aji-162	161	27	s	s	VERB
aji-162	161	28	antigens	antigen	NOUN
aji-162	161	29	,	,	PUNCT
aji-162	161	30	which	which	PRON
aji-162	161	31	are	be	AUX
aji-162	161	32	usually	usually	ADV
aji-162	161	33	part	part	NOUN
aji-162	161	34	of	of	ADP
aji-162	161	35	testing	testing	NOUN
aji-162	161	36	in	in	ADP
aji-162	161	37	the	the	DET
aji-162	161	38	mns	mns	PROPN
aji-162	161	39	blood	blood	NOUN
aji-162	161	40	group	group	NOUN
aji-162	161	41	system	system	NOUN
aji-162	161	42	.	.	PUNCT
aji-162	162	1	plus	plus	CCONJ
aji-162	162	2	,	,	PUNCT
aji-162	162	3	after	after	ADP
aji-162	162	4	treating	treat	VERB
aji-162	162	5	with	with	ADP
aji-162	162	6	dithiothreitol	dithiothreitol	PROPN
aji-162	162	7	(	(	PUNCT
aji-162	162	8	dtt	dtt	NOUN
aji-162	162	9	)	)	PUNCT
aji-162	162	10	,	,	PUNCT
aji-162	162	11	we	we	PRON
aji-162	162	12	confirmed	confirm	VERB
aji-162	162	13	that	that	SCONJ
aji-162	162	14	the	the	DET
aji-162	162	15	anti	anti	ADJ
aji-162	162	16	-	-	ADJ
aji-162	162	17	n	n	PRON
aji-162	162	18	antibody	antibody	NOUN
aji-162	162	19	was	be	AUX
aji-162	162	20	of	of	ADP
aji-162	162	21	the	the	DET
aji-162	162	22	igg	igg	PROPN
aji-162	162	23	nature	nature	NOUN
aji-162	162	24	,	,	PUNCT
aji-162	162	25	hinting	hint	VERB
aji-162	162	26	that	that	SCONJ
aji-162	162	27	it	it	PRON
aji-162	162	28	could	could	AUX
aji-162	162	29	have	have	VERB
aji-162	162	30	some	some	DET
aji-162	162	31	clinical	clinical	ADJ
aji-162	162	32	significance	significance	NOUN
aji-162	162	33	in	in	ADP
aji-162	162	34	certain	certain	ADJ
aji-162	162	35	transfusion	transfusion	NOUN
aji-162	162	36	scenarios	scenario	NOUN
aji-162	162	37	(	(	PUNCT
aji-162	162	38	sancho	sancho	NOUN
aji-162	162	39	et	et	PROPN
aji-162	162	40	al	al	PROPN
aji-162	162	41	.	.	PROPN
aji-162	162	42	,	,	PUNCT
aji-162	162	43	1998	1998	NUM
aji-162	162	44	)	)	PUNCT
aji-162	162	45	.	.	PUNCT
aji-162	163	1	finding	find	VERB
aji-162	163	2	an	an	DET
aji-162	163	3	anti	anti	ADJ
aji-162	163	4	-	-	ADJ
aji-162	163	5	n	n	PRON
aji-162	163	6	antibody	antibody	NOUN
aji-162	163	7	in	in	ADP
aji-162	163	8	a	a	DET
aji-162	163	9	healthy	healthy	ADJ
aji-162	163	10	individual	individual	NOUN
aji-162	163	11	with	with	ADP
aji-162	163	12	no	no	DET
aji-162	163	13	prior	prior	ADJ
aji-162	163	14	blood	blood	NOUN
aji-162	163	15	transfusions	transfusion	NOUN
aji-162	163	16	is	be	AUX
aji-162	163	17	pretty	pretty	ADV
aji-162	163	18	unusual	unusual	ADJ
aji-162	163	19	,	,	PUNCT
aji-162	163	20	given	give	VERB
aji-162	163	21	that	that	SCONJ
aji-162	163	22	naturally	naturally	ADV
aji-162	163	23	occurring	occur	VERB
aji-162	163	24	antibodies	antibody	NOUN
aji-162	163	25	in	in	ADP
aji-162	163	26	the	the	DET
aji-162	163	27	mns	mns	PROPN
aji-162	163	28	system	system	NOUN
aji-162	163	29	are	be	AUX
aji-162	163	30	typically	typically	ADV
aji-162	163	31	igm	igm	NOUN
aji-162	163	32	types	type	NOUN
aji-162	163	33	and	and	CCONJ
aji-162	163	34	do	do	AUX
aji-162	163	35	n’t	not	PART
aji-162	163	36	usually	usually	ADV
aji-162	163	37	trigger	trigger	VERB
aji-162	163	38	immune	immune	ADJ
aji-162	163	39	responses	response	NOUN
aji-162	163	40	.	.	PUNCT
aji-162	164	1	the	the	DET
aji-162	164	2	titer	titer	NOUN
aji-162	164	3	of	of	ADP
aji-162	164	4	1:2	1:2	NUM
aji-162	164	5	here	here	ADV
aji-162	164	6	suggests	suggest	VERB
aji-162	164	7	the	the	DET
aji-162	164	8	anti	anti	ADJ
aji-162	164	9	-	-	ADJ
aji-162	164	10	n	n	PRON
aji-162	164	11	antibody	antibody	NOUN
aji-162	164	12	could	could	AUX
aji-162	164	13	definitely	definitely	ADV
aji-162	164	14	be	be	AUX
aji-162	164	15	clinically	clinically	ADV
aji-162	164	16	important	important	ADJ
aji-162	164	17	at	at	ADP
aji-162	164	18	37	37	NUM
aji-162	164	19	°	°	NOUN
aji-162	164	20	c	c	NOUN
aji-162	164	21	(	(	PUNCT
aji-162	164	22	kumawat	kumawat	VERB
aji-162	164	23	et	et	PROPN
aji-162	164	24	al	al	PROPN
aji-162	164	25	.	.	PROPN
aji-162	164	26	,	,	PUNCT
aji-162	164	27	2015	2015	NUM
aji-162	164	28	)	)	PUNCT
aji-162	164	29	.	.	PUNCT
aji-162	165	1	this	this	PRON
aji-162	165	2	just	just	ADV
aji-162	165	3	goes	go	VERB
aji-162	165	4	to	to	PART
aji-162	165	5	show	show	VERB
aji-162	165	6	how	how	SCONJ
aji-162	165	7	important	important	ADJ
aji-162	165	8	it	it	PRON
aji-162	165	9	is	be	AUX
aji-162	165	10	to	to	PART
aji-162	165	11	do	do	VERB
aji-162	165	12	a	a	DET
aji-162	165	13	thorough	thorough	ADJ
aji-162	165	14	antibody	antibody	NOUN
aji-162	165	15	screening	screen	VERB
aji-162	165	16	for	for	ADP
aji-162	165	17	blood	blood	NOUN
aji-162	165	18	donors	donor	NOUN
aji-162	165	19	;	;	PUNCT
aji-162	165	20	even	even	ADV
aji-162	165	21	naturally	naturally	ADV
aji-162	165	22	occurring	occur	VERB
aji-162	165	23	antibodies	antibody	NOUN
aji-162	165	24	might	might	AUX
aji-162	165	25	need	need	VERB
aji-162	165	26	our	our	PRON
aji-162	165	27	attention	attention	NOUN
aji-162	165	28	in	in	ADP
aji-162	165	29	a	a	DET
aji-162	165	30	clinical	clinical	ADJ
aji-162	165	31	setting	setting	NOUN
aji-162	165	32	.	.	PUNCT
aji-162	166	1	4	4	X
aji-162	166	2	.	.	X
aji-162	166	3	conclusion	conclusion	NOUN
aji-162	166	4	in	in	ADP
aji-162	166	5	conclusion	conclusion	NOUN
aji-162	166	6	,	,	PUNCT
aji-162	166	7	this	this	DET
aji-162	166	8	case	case	NOUN
aji-162	166	9	really	really	ADV
aji-162	166	10	emphasizes	emphasize	VERB
aji-162	166	11	the	the	DET
aji-162	166	12	importance	importance	NOUN
aji-162	166	13	of	of	ADP
aji-162	166	14	rare	rare	ADJ
aji-162	166	15	blood	blood	NOUN
aji-162	166	16	group	group	NOUN
aji-162	166	17	antibodies	antibodie	VERB
aji-162	166	18	in	in	ADP
aji-162	166	19	organ	organ	NOUN
aji-162	166	20	transplantation	transplantation	NOUN
aji-162	166	21	and	and	CCONJ
aji-162	166	22	transfusion	transfusion	NOUN
aji-162	166	23	medicine	medicine	NOUN
aji-162	166	24	.	.	PUNCT
aji-162	167	1	it	it	PRON
aji-162	167	2	’s	’	VERB
aji-162	167	3	a	a	DET
aji-162	167	4	reminder	reminder	NOUN
aji-162	167	5	for	for	ADP
aji-162	167	6	clinicians	clinician	NOUN
aji-162	167	7	and	and	CCONJ
aji-162	167	8	lab	lab	NOUN
aji-162	167	9	staff	staff	NOUN
aji-162	167	10	to	to	PART
aji-162	167	11	keep	keep	VERB
aji-162	167	12	an	an	DET
aji-162	167	13	eye	eye	NOUN
aji-162	167	14	out	out	ADP
aji-162	167	15	for	for	ADP
aji-162	167	16	unusual	unusual	ADJ
aji-162	167	17	antibody	antibody	NOUN
aji-162	167	18	profiles	profile	NOUN
aji-162	167	19	,	,	PUNCT
aji-162	167	20	especially	especially	ADV
aji-162	167	21	when	when	SCONJ
aji-162	167	22	there	there	PRON
aji-162	167	23	are	be	VERB
aji-162	167	24	discrepancies	discrepancy	NOUN
aji-162	167	25	in	in	ADP
aji-162	167	26	routine	routine	ADJ
aji-162	167	27	serological	serological	ADJ
aji-162	167	28	testing	testing	NOUN
aji-162	167	29	.	.	PUNCT
aji-162	168	1	we	we	PRON
aji-162	168	2	need	need	VERB
aji-162	168	3	more	more	ADJ
aji-162	168	4	studies	study	NOUN
aji-162	168	5	and	and	CCONJ
aji-162	168	6	awareness	awareness	NOUN
aji-162	168	7	about	about	ADP
aji-162	168	8	these	these	DET
aji-162	168	9	antibodies	antibody	NOUN
aji-162	168	10	to	to	PART
aji-162	168	11	avoid	avoid	VERB
aji-162	168	12	adverse	adverse	ADJ
aji-162	168	13	reactions	reaction	NOUN
aji-162	168	14	in	in	ADP
aji-162	168	15	transfusions	transfusion	NOUN
aji-162	168	16	and	and	CCONJ
aji-162	168	17	organ	organ	NOUN
aji-162	168	18	transplant	transplant	NOUN
aji-162	168	19	procedures	procedure	NOUN
aji-162	168	20	.	.	PUNCT
aji-162	169	1	disclaimer	disclaimer	NOUN
aji-162	169	2	(	(	PUNCT
aji-162	169	3	artificial	artificial	ADJ
aji-162	169	4	intelligence	intelligence	NOUN
aji-162	169	5	)	)	PUNCT
aji-162	169	6	author(s	author(s	NOUN
aji-162	169	7	)	)	PUNCT
aji-162	169	8	hereby	hereby	ADV
aji-162	169	9	declare	declare	VERB
aji-162	169	10	that	that	SCONJ
aji-162	169	11	no	no	DET
aji-162	169	12	generative	generative	NOUN
aji-162	169	13	ai	ai	VERB
aji-162	169	14	technologies	technology	NOUN
aji-162	169	15	such	such	ADJ
aji-162	169	16	as	as	ADP
aji-162	169	17	large	large	ADJ
aji-162	169	18	language	language	NOUN
aji-162	169	19	models	model	NOUN
aji-162	169	20	(	(	PUNCT
aji-162	169	21	chatgpt	chatgpt	NOUN
aji-162	169	22	,	,	PUNCT
aji-162	169	23	copilot	copilot	NOUN
aji-162	169	24	,	,	PUNCT
aji-162	169	25	etc	etc	X
aji-162	169	26	.	.	X
aji-162	169	27	)	)	PUNCT
aji-162	169	28	and	and	CCONJ
aji-162	169	29	text	text	NOUN
aji-162	169	30	-	-	PUNCT
aji-162	169	31	to	to	ADP
aji-162	169	32	-	-	PUNCT
aji-162	169	33	image	image	NOUN
aji-162	169	34	generators	generator	NOUN
aji-162	169	35	have	have	AUX
aji-162	169	36	been	be	AUX
aji-162	169	37	used	use	VERB
aji-162	169	38	during	during	ADP
aji-162	169	39	the	the	DET
aji-162	169	40	writing	writing	NOUN
aji-162	169	41	or	or	CCONJ
aji-162	169	42	editing	editing	NOUN
aji-162	169	43	of	of	ADP
aji-162	169	44	this	this	DET
aji-162	169	45	manuscript	manuscript	NOUN
aji-162	169	46	.	.	PUNCT
aji-162	170	1	consent	consent	NOUN
aji-162	170	2	as	as	ADP
aji-162	170	3	per	per	ADP
aji-162	170	4	international	international	ADJ
aji-162	170	5	standards	standard	NOUN
aji-162	170	6	or	or	CCONJ
aji-162	170	7	university	university	NOUN
aji-162	170	8	standards	standard	NOUN
aji-162	170	9	,	,	PUNCT
aji-162	170	10	patient(s	patient(s	PROPN
aji-162	170	11	)	)	PUNCT
aji-162	170	12	written	write	VERB
aji-162	170	13	consent	consent	NOUN
aji-162	170	14	has	have	AUX
aji-162	170	15	been	be	AUX
aji-162	170	16	collected	collect	VERB
aji-162	170	17	and	and	CCONJ
aji-162	170	18	preserved	preserve	VERB
aji-162	170	19	by	by	ADP
aji-162	170	20	the	the	DET
aji-162	170	21	author(s	author(s	NOUN
aji-162	170	22	)	)	PUNCT
aji-162	170	23	.	.	PUNCT
aji-162	171	1	ethical	ethical	ADJ
aji-162	171	2	approval	approval	NOUN
aji-162	171	3	it	it	PRON
aji-162	171	4	is	be	AUX
aji-162	171	5	not	not	PART
aji-162	171	6	applicable	applicable	ADJ
aji-162	171	7	.	.	PUNCT
aji-162	172	1	competing	compete	VERB
aji-162	172	2	interests	interest	NOUN
aji-162	172	3	authors	author	NOUN
aji-162	172	4	have	have	AUX
aji-162	172	5	declared	declare	VERB
aji-162	172	6	that	that	SCONJ
aji-162	172	7	no	no	DET
aji-162	172	8	competing	compete	VERB
aji-162	172	9	interests	interest	NOUN
aji-162	172	10	exist	exist	VERB
aji-162	172	11	.	.	PUNCT
aji-162	173	1	references	reference	NOUN
aji-162	173	2	ballas	ballas	PROPN
aji-162	173	3	,	,	PUNCT
aji-162	173	4	s.	s.	PROPN
aji-162	173	5	k.	k.	PROPN
aji-162	173	6	,	,	PUNCT
aji-162	173	7	dignam	dignam	PROPN
aji-162	173	8	,	,	PUNCT
aji-162	173	9	c.	c.	PROPN
aji-162	173	10	,	,	PUNCT
aji-162	173	11	harris	harris	PROPN
aji-162	173	12	,	,	PUNCT
aji-162	173	13	m.	m.	NOUN
aji-162	173	14	,	,	PUNCT
aji-162	173	15	&	&	CCONJ
aji-162	173	16	marcolina	marcolina	PROPN
aji-162	173	17	,	,	PUNCT
aji-162	173	18	m.	m.	NOUN
aji-162	173	19	j.	j.	PROPN
aji-162	173	20	(	(	PUNCT
aji-162	173	21	1985	1985	NUM
aji-162	173	22	)	)	PUNCT
aji-162	173	23	.	.	PUNCT
aji-162	174	1	a	a	DET
aji-162	174	2	clinically	clinically	ADV
aji-162	174	3	significant	significant	ADJ
aji-162	174	4	anti	anti	NOUN
aji-162	174	5	-	-	ADJ
aji-162	174	6	n	n	ADV
aji-162	174	7	in	in	ADP
aji-162	174	8	a	a	DET
aji-162	174	9	patient	patient	NOUN
aji-162	174	10	whose	whose	DET
aji-162	174	11	red	red	ADJ
aji-162	174	12	cells	cell	NOUN
aji-162	174	13	were	be	AUX
aji-162	174	14	negative	negative	ADJ
aji-162	174	15	for	for	ADP
aji-162	174	16	n	n	PRON
aji-162	174	17	and	and	CCONJ
aji-162	174	18	u	u	NOUN
aji-162	174	19	antigens	antigen	NOUN
aji-162	174	20	.	.	PUNCT
aji-162	175	1	transfusion	transfusion	NOUN
aji-162	175	2	,	,	PUNCT
aji-162	175	3	25(4	25(4	NOUN
aji-162	175	4	)	)	PUNCT
aji-162	175	5	,	,	PUNCT
aji-162	175	6	377	377	NUM
aji-162	175	7	–	–	PUNCT
aji-162	175	8	380	380	NUM
aji-162	175	9	.	.	PUNCT
aji-162	176	1	harmening	harmene	VERB
aji-162	176	2	,	,	PUNCT
aji-162	176	3	d.	d.	PROPN
aji-162	176	4	m.	m.	PROPN
aji-162	176	5	(	(	PUNCT
aji-162	176	6	2018	2018	NUM
aji-162	176	7	)	)	PUNCT
aji-162	176	8	.	.	PUNCT
aji-162	177	1	modern	modern	ADJ
aji-162	177	2	blood	blood	NOUN
aji-162	177	3	banking	banking	NOUN
aji-162	177	4	&	&	CCONJ
aji-162	177	5	transfusion	transfusion	NOUN
aji-162	177	6	practices	practice	NOUN
aji-162	177	7	.	.	PUNCT
aji-162	178	1	fa	fa	PROPN
aji-162	178	2	davis	davis	PROPN
aji-162	178	3	.	.	PUNCT
aji-162	179	1	katagiri	katagiri	PROPN
aji-162	179	2	,	,	PUNCT
aji-162	179	3	t.	t.	PROPN
aji-162	179	4	,	,	PUNCT
aji-162	179	5	iwasaki	iwasaki	PROPN
aji-162	179	6	,	,	PUNCT
aji-162	179	7	h.	h.	PROPN
aji-162	179	8	,	,	PUNCT
aji-162	179	9	fujieda	fujieda	PROPN
aji-162	179	10	,	,	PUNCT
aji-162	179	11	a.	a.	PROPN
aji-162	179	12	,	,	PUNCT
aji-162	179	13	kasashima	kasashima	PROPN
aji-162	179	14	,	,	PUNCT
aji-162	179	15	s.	s.	PROPN
aji-162	179	16	,	,	PUNCT
aji-162	179	17	ozaki	ozaki	PROPN
aji-162	179	18	,	,	PUNCT
aji-162	179	19	s.	s.	PROPN
aji-162	179	20	,	,	PUNCT
aji-162	179	21	uemori	uemori	PROPN
aji-162	179	22	,	,	PUNCT
aji-162	179	23	m.	m.	NOUN
aji-162	179	24	,	,	PUNCT
aji-162	179	25	...	...	PUNCT
aji-162	179	26	&	&	CCONJ
aji-162	179	27	nakao	nakao	PROPN
aji-162	179	28	,	,	PUNCT
aji-162	179	29	s.	s.	PROPN
aji-162	179	30	ashfaq	ashfaq	PROPN
aji-162	179	31	and	and	CCONJ
aji-162	179	32	hasan	hasan	PROPN
aji-162	179	33	;	;	PUNCT
aji-162	179	34	asian	asian	PROPN
aji-162	179	35	j.	j.	PROPN
aji-162	179	36	immunol	immunol	PROPN
aji-162	179	37	.	.	PROPN
aji-162	179	38	,	,	PUNCT
aji-162	179	39	vol	vol	NOUN
aji-162	179	40	.	.	PROPN
aji-162	179	41	8	8	NUM
aji-162	179	42	,	,	PUNCT
aji-162	179	43	no	no	INTJ
aji-162	179	44	.	.	NOUN
aji-162	179	45	1	1	NUM
aji-162	179	46	,	,	PUNCT
aji-162	179	47	pp	pp	ADJ
aji-162	179	48	.	.	PUNCT
aji-162	180	1	82	82	NUM
aji-162	180	2	-	-	SYM
aji-162	180	3	85	85	NUM
aji-162	180	4	,	,	PUNCT
aji-162	180	5	2025	2025	NUM
aji-162	180	6	;	;	PUNCT
aji-162	180	7	article	article	NOUN
aji-162	180	8	no.aji.135018	no.aji.135018	NOUN
aji-162	180	9	85	85	NUM
aji-162	180	10	(	(	PUNCT
aji-162	180	11	2024	2024	NUM
aji-162	180	12	)	)	PUNCT
aji-162	180	13	.	.	PUNCT
aji-162	181	1	a	a	DET
aji-162	181	2	case	case	NOUN
aji-162	181	3	of	of	ADP
aji-162	181	4	hepatitis‐associated	hepatitis‐associate	VERB
aji-162	181	5	aplastic	aplastic	ADJ
aji-162	181	6	anaemia	anaemia	NOUN
aji-162	181	7	following	follow	VERB
aji-162	181	8	living‐donor	living‐donor	NOUN
aji-162	181	9	liver	liver	NOUN
aji-162	181	10	transplantation	transplantation	NOUN
aji-162	181	11	for	for	ADP
aji-162	181	12	fulminant	fulminant	ADJ
aji-162	181	13	hepatitis	hepatitis	NOUN
aji-162	181	14	showing	show	VERB
aji-162	181	15	loss	loss	NOUN
aji-162	181	16	of	of	ADP
aji-162	181	17	heterozygosity	heterozygosity	NOUN
aji-162	181	18	in	in	ADP
aji-162	181	19	the	the	DET
aji-162	181	20	6p	6p	NUM
aji-162	181	21	chromosome	chromosome	NOUN
aji-162	181	22	in	in	ADP
aji-162	181	23	the	the	DET
aji-162	181	24	affected	affected	ADJ
aji-162	181	25	liver	liver	NOUN
aji-162	181	26	.	.	PUNCT
aji-162	182	1	british	british	ADJ
aji-162	182	2	journal	journal	PROPN
aji-162	182	3	of	of	ADP
aji-162	182	4	haematology	haematology	NOUN
aji-162	182	5	,	,	PUNCT
aji-162	182	6	204(2	204(2	NUM
aji-162	182	7	)	)	PUNCT
aji-162	182	8	,	,	PUNCT
aji-162	182	9	623	623	NUM
aji-162	182	10	–	–	PUNCT
aji-162	182	11	627	627	NUM
aji-162	182	12	.	.	PUNCT
aji-162	183	1	klein	klein	PROPN
aji-162	183	2	,	,	PUNCT
aji-162	183	3	h.	h.	PROPN
aji-162	183	4	g.	g.	PROPN
aji-162	183	5	,	,	PUNCT
aji-162	183	6	&	&	CCONJ
aji-162	183	7	anstee	anstee	PROPN
aji-162	183	8	,	,	PUNCT
aji-162	183	9	d.	d.	PROPN
aji-162	183	10	j.	j.	PROPN
aji-162	183	11	(	(	PUNCT
aji-162	183	12	2013	2013	NUM
aji-162	183	13	)	)	PUNCT
aji-162	183	14	.	.	PUNCT
aji-162	184	1	mollison	mollison	NOUN
aji-162	184	2	's	's	PART
aji-162	184	3	blood	blood	NOUN
aji-162	184	4	transfusion	transfusion	NOUN
aji-162	184	5	in	in	ADP
aji-162	184	6	clinical	clinical	ADJ
aji-162	184	7	medicine	medicine	NOUN
aji-162	184	8	.	.	PUNCT
aji-162	185	1	john	john	PROPN
aji-162	185	2	wiley	wiley	PROPN
aji-162	185	3	&	&	CCONJ
aji-162	185	4	sons	son	NOUN
aji-162	185	5	.	.	PUNCT
aji-162	186	1	kumawat	kumawat	PROPN
aji-162	186	2	,	,	PUNCT
aji-162	186	3	v.	v.	PROPN
aji-162	186	4	,	,	PUNCT
aji-162	186	5	jain	jain	PROPN
aji-162	186	6	,	,	PUNCT
aji-162	186	7	a.	a.	PROPN
aji-162	186	8	,	,	PUNCT
aji-162	186	9	marwaha	marwaha	PROPN
aji-162	186	10	,	,	PUNCT
aji-162	186	11	n.	n.	NOUN
aji-162	186	12	,	,	PUNCT
aji-162	186	13	&	&	CCONJ
aji-162	186	14	sharma	sharma	PROPN
aji-162	186	15	,	,	PUNCT
aji-162	186	16	r.	r.	PROPN
aji-162	186	17	r.	r.	PROPN
aji-162	186	18	(	(	PUNCT
aji-162	186	19	2015	2015	NUM
aji-162	186	20	)	)	PUNCT
aji-162	186	21	.	.	PUNCT
aji-162	187	1	anti	anti	ADJ
aji-162	187	2	-	-	ADJ
aji-162	187	3	n	n	DET
aji-162	187	4	antibody	antibody	NOUN
aji-162	187	5	reacting	react	VERB
aji-162	187	6	at	at	ADP
aji-162	187	7	37	37	NUM
aji-162	187	8	°	°	NOUN
aji-162	187	9	c	c	NOUN
aji-162	187	10	:	:	PUNCT
aji-162	187	11	an	an	DET
aji-162	187	12	unusual	unusual	ADJ
aji-162	187	13	occurrence	occurrence	NOUN
aji-162	187	14	interfering	interfere	VERB
aji-162	187	15	with	with	ADP
aji-162	187	16	routine	routine	ADJ
aji-162	187	17	testing	testing	NOUN
aji-162	187	18	:	:	PUNCT
aji-162	187	19	two	two	NUM
aji-162	187	20	interesting	interesting	ADJ
aji-162	187	21	cases	case	NOUN
aji-162	187	22	.	.	PUNCT
aji-162	188	1	asian	asian	ADJ
aji-162	188	2	journal	journal	NOUN
aji-162	188	3	of	of	ADP
aji-162	188	4	transfusion	transfusion	NOUN
aji-162	188	5	science	science	NOUN
aji-162	188	6	,	,	PUNCT
aji-162	188	7	9(1	9(1	NUM
aji-162	188	8	)	)	PUNCT
aji-162	188	9	,	,	PUNCT
aji-162	188	10	92–93	92–93	NUM
aji-162	188	11	.	.	PUNCT
aji-162	189	1	perrault	perrault	PROPN
aji-162	189	2	,	,	PUNCT
aji-162	189	3	r.	r.	PROPN
aji-162	189	4	(	(	PUNCT
aji-162	189	5	1973	1973	NUM
aji-162	189	6	)	)	PUNCT
aji-162	189	7	.	.	PUNCT
aji-162	190	1	naturally	naturally	ADV
aji-162	190	2	-	-	PUNCT
aji-162	190	3	occurring	occur	VERB
aji-162	190	4	anti	anti	ADJ
aji-162	190	5	-	-	ADJ
aji-162	190	6	m	m	ADJ
aji-162	190	7	and	and	CCONJ
aji-162	190	8	anti	anti	ADJ
aji-162	190	9	-	-	NOUN
aji-162	190	10	n	n	ADJ
aji-162	190	11	with	with	ADP
aji-162	190	12	special	special	ADJ
aji-162	190	13	case	case	NOUN
aji-162	190	14	:	:	PUNCT
aji-162	190	15	igm	igm	NOUN
aji-162	190	16	anti	anti	PROPN
aji-162	190	17	-	-	PROPN
aji-162	190	18	n	n	ADV
aji-162	190	19	in	in	ADP
aji-162	190	20	a	a	DET
aji-162	190	21	nn	nn	X
aji-162	190	22	donor	donor	NOUN
aji-162	190	23	.	.	PUNCT
aji-162	191	1	vox	vox	PROPN
aji-162	191	2	sanguinis	sanguinis	PROPN
aji-162	191	3	,	,	PUNCT
aji-162	191	4	24(2	24(2	NUM
aji-162	191	5	)	)	PUNCT
aji-162	191	6	,	,	PUNCT
aji-162	191	7	134	134	NUM
aji-162	191	8	–	–	SYM
aji-162	191	9	149	149	NUM
aji-162	191	10	.	.	PUNCT
aji-162	192	1	sancho	sancho	PROPN
aji-162	192	2	,	,	PUNCT
aji-162	192	3	j.	j.	PROPN
aji-162	192	4	m.	m.	PROPN
aji-162	192	5	,	,	PUNCT
aji-162	192	6	pujol	pujol	NOUN
aji-162	192	7	,	,	PUNCT
aji-162	192	8	m.	m.	NOUN
aji-162	192	9	,	,	PUNCT
aji-162	192	10	fernández	fernández	PROPN
aji-162	192	11	,	,	PUNCT
aji-162	192	12	f.	f.	PROPN
aji-162	192	13	,	,	PUNCT
aji-162	192	14	soler	soler	PROPN
aji-162	192	15	,	,	PUNCT
aji-162	192	16	m.	m.	NOUN
aji-162	192	17	,	,	PUNCT
aji-162	192	18	manzano	manzano	PROPN
aji-162	192	19	,	,	PUNCT
aji-162	192	20	p.	p.	PROPN
aji-162	192	21	,	,	PUNCT
aji-162	192	22	&	&	CCONJ
aji-162	192	23	feliu	feliu	PROPN
aji-162	192	24	,	,	PUNCT
aji-162	192	25	e.	e.	PROPN
aji-162	192	26	(	(	PUNCT
aji-162	192	27	1998	1998	NUM
aji-162	192	28	)	)	PUNCT
aji-162	192	29	.	.	PUNCT
aji-162	193	1	delayed	delay	VERB
aji-162	193	2	haemolytic	haemolytic	ADJ
aji-162	193	3	transfusion	transfusion	NOUN
aji-162	193	4	reaction	reaction	NOUN
aji-162	193	5	due	due	ADP
aji-162	193	6	to	to	ADP
aji-162	193	7	anti	anti	ADJ
aji-162	193	8	-	-	ADJ
aji-162	193	9	m	m	ADJ
aji-162	193	10	antibody	antibody	NOUN
aji-162	193	11	.	.	PUNCT
aji-162	194	1	british	british	ADJ
aji-162	194	2	journal	journal	PROPN
aji-162	194	3	of	of	ADP
aji-162	194	4	haematology	haematology	NOUN
aji-162	194	5	,	,	PUNCT
aji-162	194	6	103(1	103(1	NUM
aji-162	194	7	)	)	PUNCT
aji-162	194	8	,	,	PUNCT
aji-162	194	9	268–269	268–269	NUM
aji-162	194	10	.	.	PUNCT
aji-162	195	1	taj	taj	PROPN
aji-162	195	2	,	,	PUNCT
aji-162	195	3	r.	r.	PROPN
aji-162	195	4	,	,	PUNCT
aji-162	195	5	ng	ng	PROPN
aji-162	195	6	,	,	PUNCT
aji-162	195	7	k.	k.	PROPN
aji-162	195	8	,	,	PUNCT
aji-162	195	9	cuddapah	cuddapah	PROPN
aji-162	195	10	,	,	PUNCT
aji-162	195	11	s.	s.	PROPN
aji-162	195	12	r.	r.	PROPN
aji-162	195	13	,	,	PUNCT
aji-162	195	14	rand	rand	PROPN
aji-162	195	15	,	,	PUNCT
aji-162	195	16	e.	e.	PROPN
aji-162	195	17	b.	b.	PROPN
aji-162	195	18	,	,	PUNCT
aji-162	195	19	bleicher	bleicher	PROPN
aji-162	195	20	,	,	PUNCT
aji-162	195	21	m.	m.	NOUN
aji-162	195	22	,	,	PUNCT
aji-162	195	23	amaral	amaral	PROPN
aji-162	195	24	,	,	PUNCT
aji-162	195	25	s.	s.	PROPN
aji-162	195	26	,	,	PUNCT
aji-162	195	27	...	...	PUNCT
aji-162	195	28	&	&	CCONJ
aji-162	195	29	abt	abt	PROPN
aji-162	195	30	,	,	PUNCT
aji-162	195	31	p.	p.	NOUN
aji-162	195	32	l.	l.	PROPN
aji-162	195	33	(	(	PUNCT
aji-162	195	34	2025	2025	NUM
aji-162	195	35	)	)	PUNCT
aji-162	195	36	.	.	PUNCT
aji-162	196	1	liver	liver	NOUN
aji-162	196	2	transplant	transplant	NOUN
aji-162	196	3	from	from	ADP
aji-162	196	4	a	a	DET
aji-162	196	5	deceased	deceased	ADJ
aji-162	196	6	donor	donor	NOUN
aji-162	196	7	with	with	ADP
aji-162	196	8	cystinosis	cystinosis	NOUN
aji-162	196	9	:	:	PUNCT
aji-162	196	10	a	a	DET
aji-162	196	11	case	case	NOUN
aji-162	196	12	report	report	NOUN
aji-162	196	13	.	.	PUNCT
aji-162	197	1	jimd	jimd	PROPN
aji-162	197	2	reports	report	VERB
aji-162	197	3	,	,	PUNCT
aji-162	197	4	66(1	66(1	NOUN
aji-162	197	5	)	)	PUNCT
aji-162	197	6	,	,	PUNCT
aji-162	197	7	e12467	e12467	PROPN
aji-162	197	8	.	.	PUNCT
aji-162	197	9	thakral	thakral	PROPN
aji-162	197	10	,	,	PUNCT
aji-162	197	11	b.	b.	PROPN
aji-162	197	12	,	,	PUNCT
aji-162	197	13	saluja	saluja	PROPN
aji-162	197	14	,	,	PUNCT
aji-162	197	15	k.	k.	PROPN
aji-162	197	16	,	,	PUNCT
aji-162	197	17	sharma	sharma	PROPN
aji-162	197	18	,	,	PUNCT
aji-162	197	19	r.	r.	PROPN
aji-162	197	20	r.	r.	PROPN
aji-162	197	21	,	,	PUNCT
aji-162	197	22	&	&	CCONJ
aji-162	197	23	marwaha	marwaha	PROPN
aji-162	197	24	,	,	PUNCT
aji-162	197	25	n.	n.	NOUN
aji-162	197	26	(	(	PUNCT
aji-162	197	27	2010	2010	NUM
aji-162	197	28	)	)	PUNCT
aji-162	197	29	.	.	PUNCT
aji-162	198	1	phenotype	phenotype	NOUN
aji-162	198	2	frequencies	frequency	NOUN
aji-162	198	3	of	of	ADP
aji-162	198	4	blood	blood	NOUN
aji-162	198	5	group	group	NOUN
aji-162	198	6	systems	system	NOUN
aji-162	198	7	(	(	PUNCT
aji-162	198	8	rh	rh	PROPN
aji-162	198	9	,	,	PUNCT
aji-162	198	10	kell	kell	PROPN
aji-162	198	11	,	,	PUNCT
aji-162	198	12	kidd	kidd	PROPN
aji-162	198	13	,	,	PUNCT
aji-162	198	14	duffy	duffy	PROPN
aji-162	198	15	,	,	PUNCT
aji-162	198	16	mns	mns	PROPN
aji-162	198	17	,	,	PUNCT
aji-162	198	18	p	p	X
aji-162	198	19	,	,	PUNCT
aji-162	198	20	lewis	lewis	PROPN
aji-162	198	21	,	,	PUNCT
aji-162	198	22	and	and	CCONJ
aji-162	198	23	lutheran	lutheran	NOUN
aji-162	198	24	)	)	PUNCT
aji-162	198	25	in	in	ADP
aji-162	198	26	north	north	NOUN
aji-162	198	27	indian	indian	ADJ
aji-162	198	28	blood	blood	NOUN
aji-162	198	29	donors	donor	NOUN
aji-162	198	30	.	.	PUNCT
aji-162	199	1	transfusion	transfusion	NOUN
aji-162	199	2	and	and	CCONJ
aji-162	199	3	apheresis	apheresis	NOUN
aji-162	199	4	science	science	NOUN
aji-162	199	5	:	:	PUNCT
aji-162	199	6	official	official	ADJ
aji-162	199	7	journal	journal	NOUN
aji-162	199	8	of	of	ADP
aji-162	199	9	the	the	DET
aji-162	199	10	world	world	NOUN
aji-162	199	11	apheresis	apheresis	NOUN
aji-162	199	12	association	association	NOUN
aji-162	199	13	:	:	PUNCT
aji-162	199	14	official	official	ADJ
aji-162	199	15	journal	journal	NOUN
aji-162	199	16	of	of	ADP
aji-162	199	17	the	the	DET
aji-162	199	18	european	european	PROPN
aji-162	199	19	society	society	NOUN
aji-162	199	20	for	for	ADP
aji-162	199	21	haemapheresis	haemapheresis	NOUN
aji-162	199	22	,	,	PUNCT
aji-162	199	23	43(1	43(1	NOUN
aji-162	199	24	)	)	PUNCT
aji-162	199	25	,	,	PUNCT
aji-162	199	26	17–22	17–22	NUM
aji-162	199	27	.	.	PUNCT
aji-162	200	1	wiebe	wiebe	PROPN
aji-162	200	2	,	,	PUNCT
aji-162	200	3	n.	n.	NOUN
aji-162	200	4	,	,	PUNCT
aji-162	200	5	stueck	stueck	NOUN
aji-162	200	6	,	,	PUNCT
aji-162	200	7	a.	a.	PROPN
aji-162	200	8	,	,	PUNCT
aji-162	200	9	&	&	CCONJ
aji-162	200	10	mcleod	mcleod	PROPN
aji-162	200	11	,	,	PUNCT
aji-162	200	12	m.	m.	NOUN
aji-162	200	13	(	(	PUNCT
aji-162	200	14	2024	2024	NUM
aji-162	200	15	)	)	PUNCT
aji-162	200	16	.	.	PUNCT
aji-162	201	1	steatotic	steatotic	ADJ
aji-162	201	2	liver	liver	NOUN
aji-162	201	3	disease	disease	NOUN
aji-162	201	4	arising	arise	VERB
aji-162	201	5	in	in	ADP
aji-162	201	6	an	an	DET
aji-162	201	7	asymptomatic	asymptomatic	ADJ
aji-162	201	8	20	20	NUM
aji-162	201	9	-	-	PUNCT
aji-162	201	10	year	year	NOUN
aji-162	201	11	-	-	PUNCT
aji-162	201	12	old	old	ADJ
aji-162	201	13	man	man	NOUN
aji-162	201	14	with	with	ADP
aji-162	201	15	panhypopituitarism	panhypopituitarism	NOUN
aji-162	201	16	and	and	CCONJ
aji-162	201	17	elevated	elevated	ADJ
aji-162	201	18	transaminases	transaminase	NOUN
aji-162	201	19	.	.	PUNCT
aji-162	202	1	canadian	canadian	ADJ
aji-162	202	2	liver	liver	PROPN
aji-162	202	3	journal	journal	NOUN
aji-162	202	4	,	,	PUNCT
aji-162	202	5	7(4	7(4	NUM
aji-162	202	6	)	)	PUNCT
aji-162	202	7	,	,	PUNCT
aji-162	202	8	511–516	511–516	NUM
aji-162	202	9	.	.	PUNCT
aji-162	203	1	disclaimer	disclaimer	ADJ
aji-162	203	2	/	/	SYM
aji-162	203	3	publisher	publisher	NOUN
aji-162	203	4	’s	’s	PART
aji-162	203	5	note	note	NOUN
aji-162	203	6	:	:	PUNCT
aji-162	203	7	the	the	DET
aji-162	203	8	statements	statement	NOUN
aji-162	203	9	,	,	PUNCT
aji-162	203	10	opinions	opinion	NOUN
aji-162	203	11	and	and	CCONJ
aji-162	203	12	data	datum	NOUN
aji-162	203	13	contained	contain	VERB
aji-162	203	14	in	in	ADP
aji-162	203	15	all	all	DET
aji-162	203	16	publications	publication	NOUN
aji-162	203	17	are	be	AUX
aji-162	203	18	solely	solely	ADV
aji-162	203	19	those	those	PRON
aji-162	203	20	of	of	ADP
aji-162	203	21	the	the	DET
aji-162	203	22	individual	individual	ADJ
aji-162	203	23	author(s	author(s	PROPN
aji-162	203	24	)	)	PUNCT
aji-162	203	25	and	and	CCONJ
aji-162	203	26	contributor(s	contributor(s	NOUN
aji-162	203	27	)	)	PUNCT
aji-162	203	28	and	and	CCONJ
aji-162	203	29	not	not	PART
aji-162	203	30	of	of	ADP
aji-162	203	31	the	the	DET
aji-162	203	32	publisher	publisher	NOUN
aji-162	203	33	and/or	and/or	CCONJ
aji-162	203	34	the	the	DET
aji-162	203	35	editor(s	editor(s	NOUN
aji-162	203	36	)	)	PUNCT
aji-162	203	37	.	.	PUNCT
aji-162	204	1	this	this	DET
aji-162	204	2	publisher	publisher	NOUN
aji-162	204	3	and/or	and/or	CCONJ
aji-162	204	4	the	the	DET
aji-162	204	5	editor(s	editor(s	NOUN
aji-162	204	6	)	)	PUNCT
aji-162	204	7	disclaim	disclaim	VERB
aji-162	204	8	responsibility	responsibility	NOUN
aji-162	204	9	for	for	ADP
aji-162	204	10	any	any	DET
aji-162	204	11	injury	injury	NOUN
aji-162	204	12	to	to	ADP
aji-162	204	13	people	people	NOUN
aji-162	204	14	or	or	CCONJ
aji-162	204	15	property	property	NOUN
aji-162	204	16	resulting	result	VERB
aji-162	204	17	from	from	ADP
aji-162	204	18	any	any	DET
aji-162	204	19	ideas	idea	NOUN
aji-162	204	20	,	,	PUNCT
aji-162	204	21	methods	method	NOUN
aji-162	204	22	,	,	PUNCT
aji-162	204	23	instructions	instruction	NOUN
aji-162	204	24	or	or	CCONJ
aji-162	204	25	products	product	NOUN
aji-162	204	26	referred	refer	VERB
aji-162	204	27	to	to	ADP
aji-162	204	28	in	in	ADP
aji-162	204	29	the	the	DET
aji-162	204	30	content	content	NOUN
aji-162	204	31	.	.	PUNCT
aji-162	205	1	_	_	PUNCT
aji-162	206	1	_	_	PUNCT
aji-162	207	1	_	_	PUNCT
aji-162	208	1	_	_	PUNCT
aji-162	209	1	_	_	PUNCT
aji-162	210	1	_	_	PUNCT
aji-162	211	1	_	_	PUNCT
aji-162	212	1	_	_	PUNCT
aji-162	213	1	_	_	PUNCT
aji-162	214	1	_	_	PUNCT
aji-162	215	1	_	_	PUNCT
aji-162	216	1	_	_	PUNCT
aji-162	217	1	_	_	PUNCT
aji-162	218	1	_	_	PUNCT
aji-162	219	1	_	_	PUNCT
aji-162	220	1	_	_	PUNCT
aji-162	221	1	_	_	PUNCT
aji-162	222	1	_	_	PUNCT
aji-162	223	1	_	_	PUNCT
aji-162	224	1	_	_	PUNCT
aji-162	225	1	_	_	PUNCT
aji-162	226	1	_	_	PUNCT
aji-162	227	1	_	_	PUNCT
aji-162	228	1	_	_	PUNCT
aji-162	229	1	_	_	PUNCT
aji-162	230	1	_	_	PUNCT
aji-162	231	1	_	_	PUNCT
aji-162	232	1	_	_	PUNCT
aji-162	233	1	_	_	PUNCT
aji-162	234	1	_	_	PUNCT
aji-162	235	1	_	_	PUNCT
aji-162	236	1	_	_	PUNCT
aji-162	237	1	_	_	PUNCT
aji-162	238	1	_	_	PUNCT
aji-162	239	1	_	_	PUNCT
aji-162	240	1	_	_	PUNCT
aji-162	241	1	_	_	PUNCT
aji-162	242	1	_	_	PUNCT
aji-162	243	1	_	_	PUNCT
aji-162	244	1	_	_	PUNCT
aji-162	245	1	_	_	PUNCT
aji-162	246	1	_	_	PUNCT
aji-162	247	1	_	_	PUNCT
aji-162	248	1	_	_	PUNCT
aji-162	249	1	_	_	PUNCT
aji-162	250	1	_	_	PUNCT
aji-162	251	1	_	_	PUNCT
aji-162	252	1	_	_	PUNCT
aji-162	253	1	_	_	PUNCT
aji-162	254	1	_	_	PUNCT
aji-162	255	1	_	_	PUNCT
aji-162	256	1	_	_	PUNCT
aji-162	257	1	_	_	PUNCT
aji-162	258	1	_	_	PUNCT
aji-162	259	1	_	_	PUNCT
aji-162	260	1	_	_	PUNCT
aji-162	261	1	_	_	PUNCT
aji-162	262	1	_	_	PUNCT
aji-162	263	1	_	_	PUNCT
aji-162	264	1	_	_	PUNCT
aji-162	265	1	_	_	PUNCT
aji-162	266	1	_	_	PUNCT
aji-162	267	1	_	_	PUNCT
aji-162	268	1	_	_	PUNCT
aji-162	269	1	_	_	PUNCT
aji-162	270	1	_	_	PUNCT
aji-162	271	1	_	_	PUNCT
aji-162	272	1	_	_	PUNCT
aji-162	273	1	_	_	PUNCT
aji-162	274	1	_	_	PUNCT
aji-162	275	1	_	_	PUNCT
aji-162	276	1	_	_	PUNCT
aji-162	277	1	_	_	PUNCT
aji-162	278	1	_	_	PUNCT
aji-162	279	1	_	_	PUNCT
aji-162	280	1	_	_	PUNCT
aji-162	281	1	_	_	PUNCT
aji-162	282	1	_	_	PUNCT
aji-162	283	1	_	_	PUNCT
aji-162	284	1	_	_	PUNCT
aji-162	285	1	_	_	PUNCT
aji-162	286	1	©	©	PRON
aji-162	286	2	copyright	copyright	NOUN
aji-162	286	3	(	(	PUNCT
aji-162	286	4	2025	2025	NUM
aji-162	286	5	):	):	PUNCT
aji-162	286	6	author(s	author(s	NOUN
aji-162	286	7	)	)	PUNCT
aji-162	286	8	.	.	PUNCT
aji-162	287	1	the	the	DET
aji-162	287	2	licensee	licensee	NOUN
aji-162	287	3	is	be	AUX
aji-162	287	4	the	the	DET
aji-162	287	5	journal	journal	PROPN
aji-162	287	6	publisher	publisher	NOUN
aji-162	287	7	.	.	PUNCT
aji-162	288	1	this	this	PRON
aji-162	288	2	is	be	AUX
aji-162	288	3	an	an	DET
aji-162	288	4	open	open	ADJ
aji-162	288	5	access	access	NOUN
aji-162	288	6	article	article	NOUN
aji-162	288	7	distributed	distribute	VERB
aji-162	288	8	under	under	ADP
aji-162	288	9	the	the	DET
aji-162	288	10	terms	term	NOUN
aji-162	288	11	of	of	ADP
aji-162	288	12	the	the	DET
aji-162	288	13	creative	creative	ADJ
aji-162	288	14	commons	common	NOUN
aji-162	288	15	attribution	attribution	NOUN
aji-162	288	16	license	license	NOUN
aji-162	288	17	(	(	PUNCT
aji-162	288	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-162	288	19	)	)	PUNCT
aji-162	288	20	,	,	PUNCT
aji-162	288	21	which	which	PRON
aji-162	288	22	permits	permit	VERB
aji-162	288	23	unrestricted	unrestricted	ADJ
aji-162	288	24	use	use	NOUN
aji-162	288	25	,	,	PUNCT
aji-162	288	26	distribution	distribution	NOUN
aji-162	288	27	,	,	PUNCT
aji-162	288	28	and	and	CCONJ
aji-162	288	29	reproduction	reproduction	NOUN
aji-162	288	30	in	in	ADP
aji-162	288	31	any	any	DET
aji-162	288	32	medium	medium	NOUN
aji-162	288	33	,	,	PUNCT
aji-162	288	34	provided	provide	VERB
aji-162	288	35	the	the	DET
aji-162	288	36	original	original	ADJ
aji-162	288	37	work	work	NOUN
aji-162	288	38	is	be	AUX
aji-162	288	39	properly	properly	ADV
aji-162	288	40	cited	cite	VERB
aji-162	288	41	.	.	PUNCT
aji-162	289	1	peer	peer	NOUN
aji-162	289	2	-	-	PUNCT
aji-162	289	3	review	review	NOUN
aji-162	289	4	history	history	NOUN
aji-162	289	5	:	:	PUNCT
aji-162	289	6	the	the	DET
aji-162	289	7	peer	peer	NOUN
aji-162	289	8	review	review	NOUN
aji-162	289	9	history	history	NOUN
aji-162	289	10	for	for	ADP
aji-162	289	11	this	this	DET
aji-162	289	12	paper	paper	NOUN
aji-162	289	13	can	can	AUX
aji-162	289	14	be	be	AUX
aji-162	289	15	accessed	access	VERB
aji-162	289	16	here	here	ADV
aji-162	289	17	:	:	PUNCT
aji-162	289	18	https://pr.sdiarticle5.com/review-history/135018	https://pr.sdiarticle5.com/review-history/135018	NOUN
aji-162	289	19	https://pr.sdiarticle5.com/review-history/135018	https://pr.sdiarticle5.com/review-history/135018	NOUN